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Stroke is a pervasive, devastating disease and remains one of the most 
challenging conditions to treat. In particular, risk of recurrence is 
dramatically heightened after a primary stroke and requires urgent 
preventative therapy to effectively mitigate. However, the appropriate 
preventative therapy depends on the underlying source of the stroke, known 
as etiology, which is challenging to determine promptly. Current diagnostic 
tests for determining etiology underwhelm in both sensitivity and specificity, 
and in as much as 35% of cases etiology is never determined. In ischemic 
stroke, the composition of the occluding thrombus, specifically its red blood 
cell (RBC) content, has been shown to be indicative of etiology but remains 
largely ignored within clinical practice. Currently, composition can only be 
quantified through histological analysis, an involved process that can be 
completed in only the minority of cases where a thrombus has been physically 
retrieved from the patient during treatment. 
The goal of this thesis is to develop a quantitative MR imaging method which 
is capable of non-invasive prediction of ischemic stroke etiology through 
assessment of thrombus RBC content. To achieve this goal, we employed 
quantitative MR parameters that are sensitive to both RBC content and 
oxygenation, R2* and quantitative susceptibility mapping (QSM), as well as 
fat fraction (FF) mapping, and evaluated the ability of modern artificial 
intelligence techniques to form predictions of RBC content and etiology based 
on these quantitative MR parameters alone and in combination with patient 
clinical data. 
First, we performed an in vitro blood clot imaging experiment, which sought 
to explicitly define the relationship between clot RBC content, oxygenation 




sensitive to RBC content and oxygenation, as expected, and that the 
relationship between R2* and QSM can be used to predict clot RBC content 
independent of oxygenation status, a necessary step for stroke thrombus 
characterization where oxygenation is an unknown quantity. 
Second, we trained a deep convolutional neural network to predict 
histological RBC content from ex vivo MR images of ischemic stroke thrombi. 
We demonstrate that a convolutional neural network is capable of RBC 
content prediction with 66% accuracy and 8% mean absolute error when 
trained on a limited thrombus dataset, and that prediction accuracy can be 
improved to up to 74% through data augmentation. 
Finally, we used a random forest classifier to predict clinical stroke etiology 
using the same ex vivo thrombus MR image dataset. Here, quantitative 
thrombus R2*, QSM and FF image texture features were used to train the 
classifier, and we demonstrate that this method is capable of accurate 
etiology prediction from thrombus texture information alone (accuracy = 67%, 
area under the curve (AUC) = 0.68), but that when combined with patient 
clinical data the performance of the classifier improves dramatically to an 
accuracy and AUC of 93% and 0.89, respectively. 
Together, the works presented in this thesis offer extensive ex vivo evidence 
that quantitative MR imaging is capable of effective stroke thrombus etiology 
characterization. Such a technique could enable clinical consideration of 
thrombus composition and bolster stroke etiology determination, thereby 
improving the management and care of acute ischemic stroke patients. 
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Stroke is a devastating and prevalent disease. One of the largest challenges 
in stroke treatment is rapidly determining the cause, or etiology, of the stroke 
so that the risk recurrence can be mitigated. Currently, diagnostic tests for 
etiology determination are slow and unreliable, and in about one third of 
patients etiology is never determined. In ischemic stroke, thrombus 
composition, specifically red blood cell (RBC) content, has been shown 
through histological analysis to be predictive of stroke etiology. However, 
histological analysis is too slow to be performed in an acute clinical setting; 
non-invasive imaging techniques capable of rapid stroke etiology prediction 
hold immediate value in stroke care. Currently existing techniques use 
qualitative metrics and have produced underwhelming performance; the goal 
of this thesis was to develop a quantitative MR imaging method capable of 
accurate acute ischemic stroke etiology prediction. 
In this thesis, I use the quantitative MR parameters R2*, quantitative 
susceptibility mapping (QSM) and fat fraction (FF) to characterize stroke 
thrombi. First, I showed that R2* and QSM can be used to derive a 
relationship with RBC content in blood clots in vitro. Following this, I applied 
deep learning to quantitative ex vivo thrombus MR images to predict 
histological thrombus RBC content. Finally, I used machine learning applied 
to texture features extracted from thrombus R2*, QSM and FF maps to 
predict stroke etiology using a random forest classifier. Separate models were 
built using patient clinical data and the combined set of thrombus texture 
and clinical data features. I found that the model built from imaging 
information alone was able to predict stroke etiology with comparable 
accuracy to previous qualitative models, but that when combined with 
patient clinical data the model’s performance far exceeded that of previously 




etiology in an independent test set. The works presented in this thesis offer 
extensive ex vivo evidence that quantitative MR imaging is capable of 
effective stroke thrombus etiology characterization. If implemented clinically, 
such a technique could enable consideration of thrombus composition and 
bolster stroke etiology determination, thereby improving management and 





This thesis is presented in an integrated article format, the Chapters of 
which are based on the following publications: 
Chapter 2: Christiansen S.D., Liu J., Boffa M.B., and Drangova M. 
“Simultaneous R2* and quantitative susceptibility mapping measurement 
enables differentiation of thrombus hematocrit and age: an in vitro study at 3 
T.” Journal of Neurointerventional Surgery 2019; 11.11: 1155-61. 
My contributions to this work include study conception, preparation of blood 
clots and scanning phantom, MR imaging and data collection, data analysis 
and manuscript preparation. Dr. Junmin Liu designed the MR sequence used 
in all parts of this thesis, developed the B0-NICE code used for quantitative 
MR map generation, and contributed to study conception and manuscript 
preparation. Dr. Michael Boffa improved the blood clot preparation technique 
to more realistically mimic human thrombus and contributed to manuscript 
preparation. Dr. Maria Drangova contributed to study conception, data 
interpretation and analysis, and manuscript preparation. 
Chapter 3: Christiansen S.D., Liu J., Bres Bullrich M., Sharma M., Pandey 
S.K., Boulton M., Sposato L.A., and Drangova M. “Quantitative prediction of 
stroke thrombus erythrocyte content from ex vivo multiparametric MRI using 
deep learning.” Submitted to American Journal of Neuroradiology March 
2021. 
My contributions to this work include study conception, preparation of 
scanning phantom, collection and MR imaging of stroke thrombi, data 
generation and analysis, development of the deep learning network 
architecture and code, and manuscript preparation. Dr. Junmin Liu designed 




generation, and contributed to manuscript preparation. Dr. Maria Bres 
Bullrich was responsible for the recruitment and consenting of stroke 
patients into our study, as well as contributed to manuscript preparation. 
Drs. Sharma, Pandey and Boulton contributed to stroke patient recruitment 
and manuscript preparation. Dr. Luciano Sposato contributed to stroke 
patient recruitment, study design and was responsible for the collection of 
clinical data, as well as contributed to manuscript preparation. Dr. Maria 
Drangova contributed to study conception, data interpretation and 
manuscript preparation. 
Chapter 4: Christiansen S.D., Liu J., Bres Bullrich M., Sharma M., Pandey 
S.K., Boulton M., Sposato L.A., and Drangova M. “Ex vivo thrombus MR 
imaging features and patient clinical data enable prediction of acute ischemic 
stroke etiology.” Submitted to Stroke April 2021. 
My contributions to this work include study conception, preparation of 
scanning phantom, collection and MR imaging of stroke thrombi, data 
generation and analysis, modification of the machine learning code, and 
manuscript preparation. Dr. Junmin Liu designed the MR sequence, 
developed the B0-NICE code used for quantitative MR map generation, and 
contributed to manuscript preparation. Dr. Maria Bres Bullrich was 
responsible for the recruitment and consenting of stroke patients into our 
study, as well as contributed to manuscript preparation. Drs. Sharma, 
Pandey and Boulton contributed to stroke patient recruitment and 
manuscript preparation. Dr. Luciano Sposato contributed to stroke patient 
recruitment, study design and was responsible for the collection of clinical 
data, as well as contributed to manuscript preparation. Dr. Maria Drangova 







First and foremost, I would like to thank Dr. Maria Drangova. This project 
could never have been completed without your mentorship and guidance. 
Your uncompromising drive is inspiring, and pushed me grow and improve 
myself in virtually every facet. You imbue passion, rigor and geniality in all 
those you interact, and I am honoured to have been one of your graduate 
students and grateful to learn so much from you. 
I would next like to thank Dr. Junmin Liu, who beyond developing the MR 
sequence used in every part of my research, was immensely helpful in 
troubleshooting code and guiding me to generate my first sets of image data 
early on. You have remained a consistent and thoughtful supporter; a true 
innovator and endless source of insight. 
I would also like to thank the remaining members of my advisory committee, 
Drs. Jean Théberge and Luciano Sposato, as well as Dr. Michael Boffa. You’re 
calm, cogent natures led to countless enlightening meetings; your genuine 
support and encouragement will be forever appreciated. 
I am grateful of all members of the Drangova lab I’ve had the privilege to 
work alongside, but in particular I acknowledge Dr. Zahra Hosseini, who 
welcomed me to the world of graduate school and mentored me by example. 
Joy Dunmore-Buyze and Dr. Ivailo Petrov continually remind me of all the 
things more important than work, through their empathy and humour. Trips 
to the abattoir dragged on but never outpaced your selfless characters. All 
other past and present members of the Drangova lab: Drs. Charmainne 
Cruje, Patricia Johnson, Daniel Gelman, Paul Picot, Jiro Inoue as well as 
Gregory Hong, Angad Bajwa, Miriam Hewlett, Tim Whelan, Emily Qin and 
Eric Grolman have each provided support to me in and outside of the lab in 




I acknowledge, Justina Diaz Legaspe, Maria Bres Bullrich, Ada Manini, and 
all other members of the University Hospital Endovascular Treatment Team, 
for their tireless efforts to recruit patients and save stroke thrombi for me, 
you have done everything and more to make this project possible. Dave Reese 
and Dr. Trevor Wade, and Caroline O’Neil were invaluable for the MR 
imaging and histological portions of my research, respectively. 
I finally would like to thank Greg and Dr. Raanan Marants for their 
friendship, along with every other member of our perpetually underachieving 
intramurals teams; I will cherish these years. 
This work would not have been possible had it not been for the unwavering 
support of my parents, Wendy and Roy, and my sister, Kendra; your presence 
continues to inspire me each day. And to all my friends from Scarborough, 
whose enlivened passion imbues my world with colour. Finally, I am ever 
grateful to my partner, Elizabeth, for your radiant, ambitious love. Each day 









I do not know what I may appear to the world, but to myself I seem to have 
been only like a boy playing on the sea-shore, and diverting myself in now 
and then finding a smoother pebble or a prettier shell than ordinary, whilst 
the great ocean of truth lay all undiscovered before me. 






Do not fear the shadowed truth 
Nor the hallowed light of its ingest 
At times themes sepulchral nakedly stalk 
Find comfort in their nascence and purposeful exile 
 
We can seem so small and blind 
Naively clutching at our grains of sand 
We navigate an endless implacable dessert 
Unable to sculpt the dunes  
 
But the universe in your hands is unraveling 
Humbly we bare the threads 
We tug at knots of truth and consequence 
And silently demystify the ether 
 
Ebullience crowds each knot untied 
Revealing another deeper buried in its place 
The humble pursuit of knowledge 











Dedicated to my grandparents Roni, John and Elizabeth. 
Each of whom passed on during these few short years. 
 
Dedicated to my parents, Wendy and Roy. 
For unwavering support and endearment. 
 
Dedicated to Elizabeth. 









Table of Contents 
Abstract i 
Keywords ii 
Lay Summary iii 
Co-Authorship Statement v  
Acknowledgments vii  
Dedication x 
Table of Contents xi 
List of Tables xv 
List of Figures xvi 
List of Appendices xxiii 
List of Abbreviations xxiv 
1 Introduction 1 
1.1 Motivation and overview .................................................................... 1 
1.2 Stroke mechanisms and treatment ................................................... 3 
1.3 Evolution of acute ischemic stroke care and the role of imaging ..... 5 
1.4 Stroke etiology and clinical diagnosis.............................................. 10 
1.4.1 Subtypes of acute ischemic stroke ........................................ 10 
1.4.2 Clinical determination of etiology ........................................ 12 
1.4.3 Weaknesses of the current paradigm ................................... 13 
1.5 Thrombus composition and its relationship to stroke etiology ....... 14 




1.6.1 Qualitative thrombus MR characterization  ........................ 20 
1.6.2 Effective transverse relaxation time (R2*)  ........................... 22 
1.6.3 Quantitative susceptibility mapping  ................................... 23 
1.6.4 Quantitative thrombus MR characterization  ..................... 24 
1.7 Artificial intelligence and potential for advanced thrombus analysis
 ................................................................................................................. 27 
1.7.1 Machine Learning ................................................................. 28 
1.7.2 Neural networks and deep learning ..................................... 32 
1.8 Thesis hypotheses and objectives..................................................... 36 
1.9 References ......................................................................................... 38 
 
2 Simultaneous R2* and quantitative susceptibility mapping measurement 
enables differentiation of thrombus hematocrit and age: an in vitro study at 
3T 50 
2.1 Introduction ...................................................................................... 50 
2.2 Materials and methods ..................................................................... 52 
2.2.1 Phantom preparation ............................................................ 52 
2.2.2 Image acquisition .................................................................. 53 
2.2.3 Image reconstruction and multi-parameter mapping ......... 54 
2.2.4 Image analysis ....................................................................... 55 
2.2.5 Data analysis ......................................................................... 56 
2.3 Results ............................................................................................... 56 
2.3.1 Acute clot (6 hours) ............................................................. 56 
2.3.2 Chronic clot (>6 hours) .......................................................... 57 
2.3.3 Acute and chronic clot differentiation .................................. 58 
2.3.4 Clot hematocrit prediction .................................................... 58 
2.3.5 Identification of lipid and calcifications within clot ............ 61 
2.4 Discussion ......................................................................................... 63 
2.5 Conclusion ......................................................................................... 67 




2.7 Supplementary material .................................................................. 72 
2.7.1 Methods ................................................................................. 72 
2.7.2 Results ................................................................................... 73 
2.7.3 References .............................................................................. 75 
 
3 Quantitative prediction of stroke thrombus erythrocyte content from ex vivo 
multiparametric MRI using deep learning 76 
3.1 Introduction ...................................................................................... 76 
3.2 Materials and methods ..................................................................... 78 
3.2.1 Thrombus collection and storage .......................................... 78 
3.2.2 Ex vivo thrombus imaging .................................................... 80 
3.2.3 Image processing ................................................................... 80 
3.2.4 Histological analysis ............................................................. 81 
3.2.5 Deep learning network .......................................................... 81 
3.2.5.1 Network architecture ................................................. 81 
3.2.5.2 Data augmentation .................................................... 82 
3.2.5.3 Network evaluation ................................................... 84 
3.2.6 Statistical analysis ................................................................ 85 
3.3 Results ............................................................................................... 85 
3.4 Discussion ......................................................................................... 89 
3.5 Conclusion ......................................................................................... 92 
3.6 References ......................................................................................... 94 
3.7 Supplementary material .................................................................. 98 
 
4 Ex vivo thrombus MR imaging features and patient clinical data enable 
prediction of acute ischemic stroke etiology  100 
4.1 Introduction .................................................................................... 100 
4.2 Materials and methods ................................................................... 102 




4.2.2 Thrombus storage and imaging .......................................... 103 
4.2.3 Image post processing ......................................................... 105 
4.2.4 Radiomics analysis and machine learning models ............ 105 
4.2.4.1 Feature extraction and selection ............................. 106 
4.2.4.2 Random forest analysis ........................................... 107 
4.2.5 Statistical analysis .............................................................. 108 
4.3 Results ............................................................................................. 108 
4.4 Discussion ....................................................................................... 112 
4.5 Conclusion ....................................................................................... 115 
4.6 References ....................................................................................... 116 
4.7 Supplementary material ................................................................ 121 
 
5 Conclusions and Future Directions 122 
5.1 Conclusions ..................................................................................... 122 
5.2 Limitations ...................................................................................... 124 
5.2.1 Analysis of blood clot RBC, lipid and calcium content ...... 124 
5.2.2 Prediction of stroke thrombus RBC content ...................... 125 
5.2.3 Prediction of stroke etiology ............................................... 126 
5.3 Future directions ............................................................................ 126 
5.3.1 In vitro ................................................................................. 127 
5.3.2 Ex vivo ................................................................................. 128 
5.3.3 In vivo .................................................................................. 128 
5.4 References ....................................................................................... 131 
 
A Copyright Releases 133 
 
B Ethics Approvals 141 
 





List of Tables 
1-1 Studies assessing the relationship between ischemic stroke etiology and 
histological composition of thrombi retrieved by endovascular therapy ........ 17  
3-1 Clinical details of the patient cohort for each thrombus storage group ... 79 
3-2 Performance of the CNN for thrombus histological RBC content 
prediction (T/F: true/false; ×n: training set duplication by a factor of n) ....... 86 
3-3 Performance of the CNN for thrombus histological RBC content 
prediction when limited to thrombi between 20 – 45% RBC content (T/F: 
true/false; ×n: training set duplication by a factor of n) .................................. 88 
4-1 Summary of clinical details for each patient cohort ................................ 104 
4-2 Clinical details of CE and LAA strokes within the training cohort ........ 110 
4-3 Thrombus MR imaging texture features selected by MLR for 
differentiating CE and LAA stroke within the training cohort .................... 111 
4-4 Performance of random forest classifiers for stroke etiology prediction 111 
Supp. 4-1 Texture features used in this study; more detail available in 






List of Figures 
1-1 Gross photograph of a thrombus retrieved from an acute ischemic stroke 
patient. Shown below it is the stent retriever used to remove the thrombus 
from the cerebral vessels as a part of endovascular therapy, which is 
discussed in section 1.3.  ..................................................................................... 5  
1-2 Non-contrast CT of an acute ischemic stroke patient showing signs of 
infarction by hypoattenuation of the right lentiform nucleus (arrows). Subtle 
hypoattenuation present in the acute stroke image (left) acquired 22 minutes 
after stroke onset progresses to more distinct hypoattenuation at 1 (middle) 
and 7 (right) days after stroke onset. Figure from Von Kummer et al., 
reproduced with permission.25  ........................................................................... 7  
1-3 Diffusion-perfusion MR images of an acute ischemic stroke patient 
showing mismatch in size between hyperintense lesions in the right caudate 
nucleus on DWI (left) and PWI (middle) images acquired 4.5 hours after 
stroke onset. A T2-weighted image (right) acquired 7 days after onset shows a 
final ischemic lesion that has expanded beyond the DWI lesion within the 
region of the perfusion abnormality. Figure from Baird et al., reproduced with 
permission.29  ....................................................................................................... 8 
1-4 Schematic drawing of the typical components constituting stroke thrombi. 
Activated platelets connect fibrin strands to form a webbing which 
encapsulates RBCs, WBCs, and holds the thrombus together. Isolated 
pockets of RBCs tend to form within platelet/fibrin-rich regions with WBCs 
on the border between them.63  ........................................................................ 15 
1-5 Example thrombus H&E section at low (A) and high (B) magnification 
with RBCs in red, fibrin/platelets in pink and WBCs in dark blue. An 




shown in (C). The typical thrombus has a composition of approximately 30, 60 
and 10% RBCs, fibrin/platelets and WBCs, respectively.10 Note the 
heterogeneous distribution of components, with distinct deposits of RBCs and 
fibrin/platelets arranged throughout the thrombus.  ...................................... 16 
1-6 Neurological MR (left) and CT (right) images of stroke patients 
demonstrating qualitative thrombus imaging signs; SVS and HDAS, 
respectively. Figure from Liebeskind et al., reproduced with permission.66 .. 21 
1-7 Example signal decay curve with an exponential curve fit. Higher R2* 
values correspond to a more rapidly decaying signal.  .................................... 22 
1-8 A uniform magnetic field in the presence and absence of magnetic 
material. Paramagnetic materials have a positive magnetic susceptibility and 
attract magnetic lines of force, while diamagnetic materials have a negative 
susceptibility and repel them.  ......................................................................... 23 
1-9 MR R2* (A) and QSM (B) maps of a phantom containing pairs of 
deoxygenated blood clots prepared in vitro of 10-60% RBC content (yellow 
label) with the remainder being composed of fibrin and platelets.  ................ 25 
1-10 Example thrombus (A) H&E histology slide (RBCs stain red; 
fibrin/platelets stain pink) along with a corresponding slice of its (B) GRE 
magnitude (TE = 31 ms), (C) R2* and (D) QSM maps. MR images are shown 
in a coronal view, with the vertical scanning vial walls indicated with ► and 
the thrombus outlined in cyan. Agar fills the space below the thrombus and 
outside the vials. * indicates the RBC-rich body of the thrombus which has a 
noticeably lower magnitude signal and higher R2* and QSM values than its 
fibrin-rich tail.  .................................................................................................. 26 




1-12 Diagram showing an example of texture feature value calculation from a 
second-order statistical matrix. The total number of co-occurring pairs of 
pixels across one direction in an image is used to create a gray level co-
occurrence matrix (GLCM), whose normalized values are used for the 
calculation of texture feature values. Figure from Brynolfsson et al., 
reproduced with permission.99  ......................................................................... 31 
1-13 Schematic diagram of the simple perceptron. Each connection between 
the input layers and the hidden layer nodes is associated with a tuneable 
weight parameter (wi). Each hidden layer node performs a weighted sum of 
all input features (Σi), which themselves are summed (Σj) by the output layer. 
The output is determined to be true or false based on a binary output 
function. . ........................................................................................................... 33 
1-14 Architecture of a modern CNN. Three convolutional layers are separated 
by ReLu’s and max pooling and/or batch normalization functions, followed by 
a fully connected layer with dropout before the final output layer. ............... 35 
2-1 Acute blood clot relaxation and magnetic susceptibility quantification; 
shown are the central coronal slices of the (A) R2* [0 s-1, 80 s-1] and (B) QSM 
[-0.5 ppm, 0.5 ppm] maps for the blood-only thrombus phantom at 6 hours 
post clotting. The mean (C) R2* and (D) QSM values of an individual clot from 
each pair (10 to 60% hematocrit) are shown over the first 6 hours post 
clotting; error bars were omitted for clarity. The mean and standard 
deviation of each clot pair with the same nominal hematocrit at the six hour 
time point are shown for (E) R2* and (F) QSM, demonstrating reproducibility. 
 ........................................................................................................................... 57 
2-2 Blood clot R2* and QSM of chronic clots throughout ageing; (A) R2* and (B) 
QSM values of blood-only clots from 6 up to 144 hours post clotting (the 6-hr 
time point is included in order to relate these results to those of the acute 




deviation error bars of only the 60% hematocrit clots are shown for clarity, 
error bars for QSM were smaller than the symbols. (C) Scatter plot and linear 
regression of R2* versus QSM values at all time points for clots of each 
hematocrit.  ....................................................................................................... 59 
2-3 Relationship between hematocrit and measured quantitative imaging 
values in acute (≤6 hours) and chronic (>6 hours) clot. (A) Acute clot 
hematocrit can be estimated linearly from measured QSM values, while (B) 
chronic clot hematocrit can be estimated from an exponential relation of the 
ratio of R2* / QSM. Shown are data points from the same 6 clots (one from 
each pair of 10 to 60% hematocrit) plotted in Figures 2-1 and 2-2.  ............... 60 
2-4 Regions (1.2 × 1.4 mm) from representative sagittal slices through select 
clots (0, 20, 40% hematocrit) in the lard clot phantom demonstrating 
discriminability of the added component; shown are early and late echo 
magnitude images of clots within the phantom at (A) 7 hours and (B) 4 days 
post clotting. These images represent the current standard technique for 
thrombus characterization; lard is either visible within clot as a nondescript 
area of low signal (red arrows) or is undetectable because of signal void 
produced by chronic clot (B; 20 and 40% clots at 31 ms). R2*, QSM and fat 
fraction (FF) maps of the phantom are shown at (C) 7 hours and (D) 4 days 
post clotting. Lipid is readily distinguishable from clot by its elevated FF 
value in clots of all hematocrits whether acute or chronic. Noticeable 
differences in R2* and QSM values between clots of different hematocrit can 
also be observed in the chronic clots in (D).  .................................................... 62 
2-5 Regions (1.2 × 1.4 mm) from representative sagittal slices through a 
single whole-blood clot with an added piece of agar containing 5M calcium 
carbonate (red arrows); shown are early and late echo magnitude images at 
(A) 2 hours and (B) 2 days post clotting. Similar to the appearance of the lard 




magnitude images, but differs with high R2*, low QSM and low FF values. 
The calcium carbonate is definitively identified within both acute and chronic 
clot by its negative QSM values (black in the QSM maps of (B)).  ................. 62 
Supp. 2-1 Central coronal slices of the (A) B0-NICE fat fraction (FF) [0, 1], (B) 
MEDI quantitative susceptibility mapping (QSM) [-1.25 ppm, 3.25 ppm] and 
(c) B0-NICE R2* [0 s-1, 350 s-1] maps. For the FF phantom (A) the nominal 
fat fraction of each vial is identified; unlabeled vials contain both fat and 
Gadolinium (Gd) and were not analyzed. For the susceptibility phantom (B, 
C), labels show Gd concentration (mM); unlabeled vials contain oil/water 
emulsions. (D) B0-NICE FF plotted against FF measured using the IDEAL 
sequence; (E) measured QSM against expected sample susceptibility; (F) B0-
NICE-derived R2* is plotted against Gd concentration. Error bars represent 
the standard deviation of all pixels within each region of interest. Note that 
the oil vial displays an artifactual diamagnetic susceptibility on the QSM 
map because of the varying fat-water phase shifts in the processed echoes. . 74 
3-1 Schematic diagram of the CNN. Three-dimensional RGB images 
consisting of segmented, normalized thrombus R2*, QSM and GRE magnitude 
images are fed into a network consisting of 3 convolutions layers with 
average pooling layers in between and a dropout layer at the end, before a 
final fully-connected layer. Padding is employed to retain image size in the 
convolutional layers. ......................................................................................... 82 
3-2 Representative training set thrombus RBC content distribution (A) before 
and (B) after input sampling equalization.  ..................................................... 83 
3-3 An example normalized, segmented thrombus RGB image slice is shown 
(A) before and (B) after random image transformation. R2*, QSM and GRE 
magnitude pixel values represent the red, green and blue image color 




3-4 Linear regression plots of the CNN predicted thrombus RBC content 
against the histological value for best-performing network iterations on the 
equalized, transformed dataset with (A) ×1, (B) ×3, and (C) ×5 duplication, 
respectively. Plotted are the median predictions from all MR slices available 
for each thrombus. These same predictions replotted with only thrombi with 
histological RBC content between 20 – 45% are shown in (D), (E) and (F), 
respectively.  ...................................................................................................... 88 
Supp. 3-1 Bland-Altman plot showing the difference between thrombus 
histological RBC content and that predicted through mean R2* and QSM 
values using the methods described in Chapter 2. Predicted RBC content 
consistently underestimated the histological values, yielding a mean error of 
20 ± 22% and a mean absolute error of 25 ± 16%.  .......................................... 98 
Supp. 3-2 Effect of storage method and time between thrombus retrieval and 
MR imaging on mean thrombus (A) R2* and (B) QSM values. Thrombi were 
either stored at room temperature and scanned within the same workday, or 
stored in a fridge until the next available workday. Two-tailed T-tests 
between the two groups R2* and QSM values yielded significant differences 
with p = 0.0005 and p = 0.02, respectively.  ..................................................... 98 
Supp. 3-3 Thrombus multi-section histological results. Mean RBC content is 
shown at 3 or 4 evenly spaced intervals through the retrieved stroke thrombi. 
Red dots indicate the average RBC content values at each slice for all 
thrombi. ............................................................................................................. 99 
4-1 Representative segmented thrombus R2* (top), QSM (middle) and FF 
(bottom) images shown in (A) original form, (B) after equal-probability 
quantization with 64 bins and (C) after uniform quantization with 8 bins. 
These extraction parameters control the pixel distribution and coarseness 




4-2 ROC curves for the determination of CE vs. LAA stroke etiology within 
the training (A) and validation (B) cohorts using the imaging, clinical and 
combined random forest classifier models. .................................................... 111 
5-1 Axial time of flight (TOF) angiography, R2*, QSM and FF maps of an 
ischemic stroke patient with intracranial thrombus (arrow) of 
atherothrombotic origin. High R2* and QSM indicate a deoxygenated, RBC-


















List of Appendices 
Copyright Releases 133 
Ethics Approvals 141 






List of Abbreviations 
3D  three-dimensional 
AIS  acute ischemic stroke 
AUC  area under the ROC curve 
CE  cardioembolism 
CNN  convolutional neural network 
CT  computed tomography 
CTP  computed tomography perfusion 
DWI  diffusion-weighted imaging 
EVT  endovascular therapy 
FF  fat fraction 
Gd  gadolinium 
GRE  gradient recalled echo 
H&E  hematoxylin and eosin 
HDAS hyperdense artery sign 
HU  Hounsfield unit 
LAA  large-artery atherosclerosis 
MEDI  morphology enabled dipole inversion 
MCA  middle cerebral artery 
MLR  multivariate logistic regression 
MR  magnetic resonance 
PPP  platelet-poor plasma 
PRP  platelet-rich plasma 
PWI  perfusion-weighted imaging 
QSM  quantitative susceptibility mapping 
RBC  red blood cell 
ReLu  rectified linear unit 
RMSE root mean square error 




ROC  receiver operator characteristic 
ROI  region of interest 
rtPA  recombinant tissue plasminogen activator 
SVO  small-vessel occlusion 
SVS  susceptibility vessel sign 
T2*  transverse relaxation rate 
TE  echo time 
TOAST trial of ORG 10172 in acute stroke treatment 
TOF  time of flight 
TR  repetition time 



















1.1 Motivation and overview 
Stroke represents one of the most prevalent and devastating diseases across 
the world. In 2013, stroke was the second most common cause of death and 
third most common cause of disability worldwide.1 In Canada, one stroke is 
said to occur every 10 minutes, and collectively stroke is responsible for an 
economic burden of over $3.6 billion in direct costs annually.2 While recent 
years have seen the incidence, mortality and disability burden of stroke 
decline,3 the number of people who are affected by stroke in any form (deaths, 
survivors, and those who remain disabled) is increasing.1 
Patients who have survived their first stroke are over 10 times more likely to 
have a second within 12 months compared to those with no stroke history,4,5 
and these secondary strokes are more likely to be fatal or disabling than the 
first.6 With the number of stroke survivors in Canada expected to increase by 
1.5 to 2 times between 2013 and 2038,7 there is a growing population of 
individuals with heightened stroke risk who require prophylactic therapy to 
minimize their risk of stroke recurrence. The optimal therapy for limiting 
recurrence is specific to the underlying etiology (cause) of the primary stroke, 
however etiology may takes weeks to determine, and even following extensive 
clinical testing remains unknown in as much as 35% of cases.8 
Medical imaging, through x-ray, ultrasound, computed tomography (CT) and 
magnetic resonance (MR) imaging, serves a vital role within acute stroke 




identify whether a stroke is ischemic or hemorrhagic in nature, a critical 
disease characteristic which determines the course of stroke treatment.9 
However, no attempt is currently made to use imaging techniques to deduce 
stroke etiology beyond the use of x-ray angiography and echocardiography to 
search for signs of atherosclerotic stenosis and arrhythmia, respectively; 
these have proven to be inconsistent and unreliable indicators. This approach 
fails to take advantage of all the information available from acute imaging, 
and in ischemic stroke in particular, ignores the information available from 
within the thrombus (blood clot) itself. Evidence is mounting to suggest that 
thrombus composition may be indicative of underlying stroke etiology.8,10,11 
Presently, the only method to assess thrombus composition is histological 
analysis, but this can only be completed in cases where a thrombus has been 
physically retrieved from the patient during treatment. The benefit of an 
imaging method capable of non-invasively identifying thrombus composition 
is immeasurable, and there remains ample room for improvement amongst 
current experimental imaging techniques. 
Admittedly, because stroke care is extremely time-sensitive, access to 
advanced imaging scanners, particularly for MR imaging, is a challenge for 
many centres and limits the ability to add new imaging techniques to stroke 
protocols. However, the increasing accessibility of MR and CT scanners, 
combined with recent recommendations from the American Heart Association 
that stroke patients presenting within 6 – 24 hours of symptom onset receive 
advanced imaging (MR or CT) to guide therapy,12 means that the number of 
patients for which advanced imaging can be completed is only increasing. 
This thesis describes the development and validation of novel MR imaging 
analysis techniques aimed at quantitatively predicting the composition and 
etiology of acute ischemic stroke thrombi. The work presented herein first 
demonstrates the sensitivity of the relevant quantitative MR imaging 




2), followed by an evaluation of composition inference (Chapter 3) and 
etiology prediction (Chapter 4) using deep learning and machine learning, 
respectively, applied to quantitative MR images of retrieved acute stroke 
thrombi ex vivo. This introductory chapter provides a comprehensive 
overview to motivate the work presented in the following chapters, beginning 
with a description of the pathophysiologic mechanisms of stroke (1.2), 
followed by the evolution of acute stroke care (1.3), current stroke etiology 
determination techniques and their associated limitations (1.4), histological 
relationships between thrombus composition and etiology (1.5), previously 
developed imaging techniques for thrombus composition and etiology 
prediction (1.6), modern machine and deep learning image analysis 
techniques and their potential for improved thrombus characterization (1.7), 
and finally the hypothesis and objectives of this thesis (1.8). 
 
1.2 Stroke mechanisms and treatment 
A stroke occurs when brain cells are damaged due to improper blood flow, 
and may occur due to lack of blood from vessel blockage (ischemic) or 
compression from an internal bleed (hemorrhagic). For the former, treatment 
consists of restoration of blood flow to the affected tissue. The derived benefit 
from reperfusion depends strongly on the length of time the brain has faced 
oxygen deprivation. Assessment of the affected tissue’s viability and 
prediction of the brain’s response to reperfusion is the most important task 
faced by stroke interventionalists treating ischemic stroke. 
A stroke occurs when brain tissue is injured by either a deprivation of 
oxygenated blood supply or hydrostatic pressure from an internal bleed, to an 
extent and duration upon which neurological symptoms of impairment begin 




disruption leading to ion channel failure, sodium, chloride and then water 
influx, while internal bleeding results in the mechanical disruption and 
deformation of cells, mitochondrial dysfunction and membrane 
depolarisation.13,14 Both mechanisms result in cell swelling (cytotoxic edema) 
and, eventually, to irreversible cell death. Symptoms of stroke vary widely 
depending on the region facing injury, but most commonly manifest as acute 
one-sided weakness (hemiparesis), facial droop, difficulty understanding and 
formulating speech (aphasia), unclear speech (dysarthria), visual field 
deficits, headaches and/or lack of muscle coordination (ataxia).15 Strokes 
occurring as a result of hypoxia are referred to as ischemic while those due to 
internal bleeding are referred to as hemorrhagic. Ischemic strokes, the focus 
of this thesis, represent approximately 80% of all strokes,16 and are most 
commonly caused by thrombi which have embolized from a downstream 
artery and were halted within the narrowing cerebral vessels, disrupting 
blood flow. A photograph of a retrieved ischemic stroke thrombus is shown in 
Figure 1-1. Less commonly, thrombi may form in situ directly within cerebral 
arteries (lacunar stroke),17 or, less commonly still, stroke may be caused be 
the embolization of materials other than thrombus, including fat, calcium, 
air, infected (septic) tissue or tumour (usually myxoma).18 
In all cases, the treatment for ischemic stroke is reperfusion therapy; 
restoration of blood flow to the ischemic areas. In principle, complete 
reperfusion of affected tissue can lead to the eradication of symptoms and 
near-instant recovery, if all affected tissue is still viable. In practice, complete 
reperfusion is rarely achieved, may serve no benefit to tissue which has 
already been irreversibly infarcted, and may actually cause damage to 
surrounding viable tissue through hemorrhage of areas reperfused with a 
blood brain barrier disrupted by ischemia.19 Failure to achieve reperfusion in 
viable tissue however can lead to permanent disability or death, and while 




phenomenal degree, a process known as neuroplasticity, a return to pre-
stroke capability rarely occurs.20 Determination of the amount of salvageable 
tissue, and the risks associated with treatment, is therefore the critical task 
for stroke interventionalists treating ischemic stroke. Methods for achieving 
reperfusion have thus developed in tandem with strategies to identify the 
patients most likely to derive benefit. 
 
Figure 1-1: Gross photograph of a thrombus retrieved from an acute ischemic 
stroke patient. Shown below it is the stent retriever used to remove the 
thrombus from the cerebral vessels as a part of endovascular therapy, which 
is discussed in section 1.3. 
 
1.3 Evolution of acute ischemic stroke care and the role of 
imaging 
Our understanding of stroke and its optimal care continues to evolve. 
Reperfusion is currently the only treatment and two clinically approved 
techniques to achieve this exist today: thrombus lysis by recombinant tissue 
plasminogen activator and extraction by endovascular therapy. Each has 
seen its usefulness and impact expand since it was first approved, and in 




therapy opens the door for increased involvement of advanced imaging 
techniques within acute stroke care. 
The first recorded description of stroke came in the 4th century BCE from 
Hippocrates, who termed a set of symptoms that included sudden onset 
paralysis, loss of consciousness and death as “apoplexy,” meaning “struck 
down violently.”21 Since then, our understanding of the causes and 
mechanisms of stroke have grown enormously, and yet only recently has 
modern medicine been capable of direct treatment. Up until the 1990’s, 
stroke treatment consisted largely of supportive care and the prevention of 
complications.21 Following the results of a 1995 National Institute of 
Neurological Disorders and Stroke recombinant tissue plasminogen activator 
(rtPA) study,22 the Food and Drug Administration approved the use of 
intravenous rtPA for ischemic stroke patients within 3 hours of symptom 
onset in 1996.23 rtPA is a synthetic version of the naturally occurring human 
clot-dissolving protein, tissue plasminogen activator, and was initially 
indicated for all ischemic stroke patients under 3 hours post-onset lacking 
contraindications to the drug. Further studies and clinical trials 
demonstrated that rtPA could be beneficial for patients up to 4.5 hours after 
onset if those presenting with severe infarction, and therefore low tissue 




Figure 1-2: Non-contrast CT of an acute ischemic stroke patient showing 
signs of infarction by hypoattenuation of the right lentiform nucleus (arrows). 
Subtle hypoattenuation present in the acute stroke image (left) acquired 22 
minutes after stroke onset progresses to more distinct hypoattenuation at 1 
(middle) and 7 (right) days after stroke onset. Figure from Von Kummer et 
al., reproduced with permission.26 
CT is capable of detecting severe edema associated with infarction through 
hypoattenuation within brain parenchyma, as shown in Figure 1-2. The 
number and extent of hypointense lesions is associated with risk of 
hemorrhagic transform following rtPA administration.27 However, non-
contrast CT possesses a relatively poor sensitivity (~65%) for detecting acute 
stroke lesions,26 and lacks the ability to identify tissue at risk of infarction 
but not yet beyond the threshold of irreversible damage. Hypoperfused tissue 
that is salvageable but will proceed to infarction if left untreated is referred 
to as the stroke “penumbra,” while ischemic tissue that has already past the 
point of irreversible damage and will infarct is deemed the “core.”28 In 
conjunction with the rising prominence of rtPA treatment came MR studies 
demonstrating the potential for diffusion-weighted imaging (DWI) to 
visualize the infarct core along with perfusion-weighted imaging (PWI) to 
show the penumbra.29,30 A mismatch between DWI and PWI lesions indicates 
the presence of vulnerable penumbral tissue that will proceed to infarction if 




(DEFUSE) demonstrated promise that DWI and PWI could be used to 
identify patients who would respond positively to rtPA for up to 6 hours after 
onset, showing that patients with mismatched DWI/PWI lesions responded 
better than those with similar lesion sizes at presentation.31 However, a later 
randomized controlled trial (EPITHET) into the use of DWI/PWI failed to 
show a difference in benefit between patients given rtPA with and without a 
mismatch.32 As a consequence, advanced imaging selection for rtPA 
administration was never widely adopted into the clinic and the 2018 
Canadian stroke guidelines recommend no input from imaging for the 
decision beyond examining for hemorrhage and infarction severity on CT.33 
 
Figure 1-3: Diffusion-perfusion MR images of an acute ischemic stroke 
patient showing mismatch in size between hyperintense lesions in the right 
caudate nucleus on DWI (left) and PWI (middle) images acquired 4.5 hours 
after stroke onset. A T2-weighted image (right) acquired 7 days after onset 
shows a final ischemic lesion that has expanded beyond the DWI lesion 
within the region of the perfusion abnormality. Figure from Baird et al., 
reproduced with permission.30 
However, in recent years the use of imaging to illuminate penumbral and 
core tissue has seen a resurgence with the advent of endovascular therapy, 
the use of an inserted stent retriever (mechanical thrombectomy) or aspirator 
to physically remove the occluding thrombus. A 2012 prospective study 




endovascular therapy within 12 hours of onset.34 Contemporaneously, CT 
perfusion (CTP) imaging was gaining prominence as a tool for penumbral 
stroke imaging, and was shown to provide a comparable assessment of 
ischemic core and penumbra as DWI and PWI.35 A 2014 randomized clinical 
trial (EXTEND-IA) demonstrated benefit for endovascular therapy in 
patients stratified by CTP-based perfusion mismatch assessments within 8 
hours of symptom onset.36 By the mid-2010’s, the utility of advanced (MR or 
CT) imaging for selecting patients suitable for endovascular therapy was well 
documented, but given the relatively short accepted time window for which 
patients could be treated (6 – 8 hours in most centres), only a fraction of 
stroke patients were eligible and in Canada advanced imaging selection was 
not formally recommended unless it could be done without any delay of 
treatment administration.37 Recently, two randomized, controlled trials 
(DAWN, DEFUSE 3) demonstrated clear evidence in favour of using 
advanced, perfusion-based imaging (MR or CTP) to identify patients most 
likely to benefit from endovascular therapy, and notably this was 
demonstrated in patients at up to 24 hours after stroke onset.38,39 Following 
the release of these trials, stroke guidelines were updated and today 
advanced imaging is recommended for ischemic stroke patients arriving 
between 6 – 24 hours after symptom onset to select patients likely to benefit 
from therapy; stroke centres are expected to see a significant increase in the 
number of patients eligible for advanced imaging and endovascular therapy 
subsequent to the implementation of these guidelines.9 Such an increase also 
creates opportunity for adoption of novel imaging acquisitions, which expand 
the information available to clinicians during acute stroke treatment. Beyond 
selecting patients appropriate for acute treatment, imaging also offers 
potential for improving patient care during their recovery; namely in 
identifying the underlying cause of the primary stroke so that the risk of 




1.4 Stroke etiology and clinical diagnosis 
A number of potential mechanisms can be responsible for ischemic stroke. 
The need to identify the underlying cause, or etiology, of a stroke is critical 
given the elevated risk of recurrence after primary stroke as the most 
effective risk-mitigating therapy differs between etiologies. In particular, 
cardioembolic and large artery atherosclerotic stroke are the most common 
etiologies and require different antithrombotic drugs to optimally limit their 
chance of recurrence; cardioembolic strokes are most often caused by 
arrhythmias, which can be challenging to detect within the post-stroke 
window of elevated secondary stroke risk. 
Stroke is a unique disease in that the risk of recurrence is vastly increased 
after an initial stroke has occurred; within one year the risk of recurrence is 
approximately 13%, over 10 times the risk in the general population.40 
Compounding this is the unfortunate fact that secondary strokes are typically 
more devastating than the first. Accordingly, identifying the underlying 
cause, or etiology, of a stroke so that the patient may be treated to optimally 
mitigate the risk of recurrence is a critical component of stroke care. There 
are myriad different causes, known as subtypes, of ischemic stroke and these 
will be detailed in the following section before current strategies for etiology 
determination, and their associated weaknesses, are discussed. 
  1.4.1 Subtypes of acute ischemic stroke 
The Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification 
system,41 developed in the 1990’s, remains the most widely used system to 
categorize stroke subtype in clinics today, largely due to its simplicity relative 
to later proposed schemes.42 TOAST stratifies ischemic stroke into one of 5 




vessel occlusion (SVO), stroke of other determined etiology and stroke of 
undetermined etiology. 
LAA is diagnosed in approximately 25% of all ischemic strokes,43 and occurs 
subsequent to an immunoinflammatory reaction to circulating blood 
cholesterol resulting in atherosclerotic plaque formation within the vessel 
wall of a major feeding artery to the brain (typically the internal carotid 
artery).44 The growing plaque expands into the vessel lumen and often, but 
not always, ruptures prior to inducing thrombosis on its surface; the nascent 
thrombus eventually embolizes to the intracranial arteries.45 Almost 
everyone develops detectable atherosclerosis within intracranial vessels as 
they age,46 and the risk of LAA stroke has been correlated to its severity.47 
CE is diagnosed in between 20 to 40% of ischemic strokes and is resultant 
from a vast number of potential mechanisms, the original TOAST paper lists 
over 20 possible sources,41 but most commonly occurs from complications of 
atrial fibrillation. Atrial fibrillation is a sporadic, often asymptomatic 
arrhythmia of the heart that causes blood to flow poorly and stagnate within 
its chambers, eventually leading to thrombus formation. When no 
concomitant valvular disease is present (70-96% of AF cases),48 90% of AF-
induced thrombi form within the left atrial appendage,49 where they can sit 
for weeks or perhaps months at a time prior to embolization.50 AF is present 
in only 1% of adults (9% of those 80 and older), but entails a 5-fold overall 
increase in stroke risk compared to those in normal sinus rhythm.51 
SVO, also known as lacunar stroke, is diagnosed in approximately 15% of 
ischemic strokes and is defined as a stroke that occurs within the subcortical 
vessels of the brain. SVO occurs either through lipohyalinosis, a fibrotic 
vessel wall thickening, or intracranial atherosclerosis through a process 
originally thought to be distinct from the cervicocranial atherosclerosis 




including diabetes and hypertension.41 However, more recent work has 
demonstrated no difference in the risk factor profiles between SVO stroke 
patients and those of other types.53 SVO strokes are comparably less severe 
than those from LAA and CE,54 as they necessarily involve smaller vessels 
with less overall impact on cerebral perfusion, and will not be discussed 
further in this thesis. 
Strokes of other determined etiology represent approximately 5% of ischemic 
stroke cases and consist of the miscellaneous, uncommon causes of stroke 
including dissection, other nonatheroslerotic vasculopathies, hypercoagulable 
states and hematologic disorders.41 
Strokes of undetermined etiology account for approximately 35% of ischemic 
strokes, though this number varies widely between stroke sites due to 
differences in clinical practice and resources. This subtype includes both 
strokes whose cause could not be identified following clinical evaluation, and 
those in which two or more potential, conflicting causes were identified. 
There is evidence to suggest that the majority of undetermined strokes are 
CE in origin, following the missed diagnosis of arrythmia.8 
1.4.2 Clinical determination of etiology 
The current clinical approach for identifying stroke etiology follows from that 
prescribed by the original TOAST criteria; LAA is considered if significant 
stenosis (>50%) can be found in any major ipsilateral carotid artery, in 
absence of the 20+ risk factors that indicate CE, and vice versa.41 Stenosis is 
typically evaluated through an x-ray angiogram, while AF, if not previously 
diagnosed, is searched for through echocardiographic and 
electrocardiographic (ECG) monitoring during a patient’s hospital stay prior 
to long-term observation at home with an external ECG monitor for at least 2 




through a wide variety of means, including ultrasound imaging, laboratory 
blood tests and examining clinical history. These etiologies vary in their 
difficulty to identify, but are uncommon and their clinical impact is relatively 
minor compared to that of the LAA and CE subtypes. 
1.4.3 Weaknesses of the current paradigm 
Following an ischemic stroke, antiplatelet drugs are routinely given to reduce 
the risk of stroke recurrence. However, for CE strokes caused by AF, 
antiplatelets are only moderately effective compared to anticoagulant 
drugs56,57 but these can only be given after a diagnosis of AF is made.55 
Because AF can be paroxysmal, it is often not detected during a patients 
short term hospital stay and patients are sent home to complete long-term 
cardiac monitoring with an ineffective therapy, thereby unnecessarily 
heightening their risk of stroke recurrence. Beyond this, in as many as 1 in 3 
patients with AF the arrhythmia is not detected even after 30 days of at-
home monitoring.58 
For LAA strokes, the arbitrary cutoff of >50% stenosis for diagnosis has been 
criticized as it incorrectly classifies those with less than 50% as a stroke of 
undetermined etiology, and may confound other classifications such as CE if 
a stenosis is found but is asymptomatic and unrelated to the stroke.59 One 
study has found significant (>50%) stenosis in nearly 25% of ischemic stroke 
patients with AF; in these cases the stroke would also be classified stroke of 
undetermined etiology, due to multiple identified causes.60 
Overall, the methods used by clinicians today to deduce etiology are 
insensitive and unspecific; decisive criteria are neither definitive nor 
mutually exclusive and the origin of many strokes is never determined. As 
such, there is ample room for clinicians to consider additional information 




information contained within stroke thrombi, the underlying cause of 
ischemic stroke itself, is available to be leveraged but currently remains 
ignored within clinical practice. 
 
1.5 Thrombus composition and its relationship to stroke 
etiology 
There remains significant room for improvement in the determination of 
ischemic stroke etiology, and an area that has thus far being inadequately 
explored is the information present within the thrombus itself; its 
composition. An accumulation of histological studies have demonstrated a 
link between thrombus RBC content and stroke subtype. Knowledge of 
thrombus RBC content has the potential to guide and improve acute stroke 
care, but histological analysis is not possible to perform in the many cases 
where a thrombus is not retrieved. Rapid, non-invasive assessment through 
medical imaging is required for thrombus composition to be considered within 
acute stroke care. 
Four major components constitute the vast majority of all thrombi: red blood 
cells (RBCs), fibrin, platelets, and white blood cells (WBCs). A schematic 
diagram depicting these components within stroke thrombi is shown in 
Figure 1-4. Thrombus formation is initiated by thrombin generation through 
either the collagen- (intrinsic) or tissue factor- (extrinsic) dependent 
pathways, which cause the development of fibrin strands from circulating 
fibrinogen segments as well as the activation of platelets that bind to and 
connect fibrin strands together to form a mesh-like structure.61 Platelet 
activation causes the recruitment of WBCs into the nascent thrombus, 
initiating an immunoinflammatory response which accompanies and 




thrombi via passive entrapment in the fibrin mesh, and the scope of their 
influence over thrombosis is still not fully understood.63 Occasionally, 
additional components present at the site of thrombus formation, such as 
lipid in the form of cholesterol crystals and calcium hydroxyapatite from 
intravascular calcifications, may be incorporated into a thrombus as well. 
 
Figure 1-4: Schematic drawing of the typical components constituting stroke 
thrombi. Activated platelets connect fibrin strands to form a webbing which 
encapsulates RBCs, WBCs, and holds the thrombus together. Isolated 
pockets of RBCs tend to form within platelet/fibrin-rich regions with WBCs 
on the border between them.64 
The relative proportion of each of these components varies widely between 
thrombi, as they are influenced by the specific conditions under which 
thrombosis occurred. Variability in blood flow within stenotic vessels has 
been linked to heterogeneous deposition of platelets, for example.65 
Consequently, the composition of an embolic thrombus may be indicative of 
its source. Numerous studies have attempted to derive relationships between 





Histological examination involves the dehydration, embedding, slicing and 
staining of tissue samples for examination under a microscope. It provides 
the gold-standard assessment of tissue composition through microscopic 
resolution images of slides, which are stained to illuminate a wide array of 
cellular and non-cellular components. Hematoxylin and eosin (H&E) is the 
most common stain used for thrombus histological analysis; it uniquely 
identifies RBC and WBC components but cannot distinguish between fibrin 
and platelets. These stain images can be segmented to quantitatively assess 
the proportion of all components within a thrombus section. An example 
thrombus H&E stain image and segmentation is shown in Figure 1-5. 
 
Figure 1-5: Example thrombus H&E section at low (A) and high (B) 
magnification with RBCs in red, fibrin/platelets in pink and WBCs in dark 
blue. An example segmentation output used to quantify thrombus 
composition is shown in (C). The typical thrombus has a composition of 
approximately 30, 60 and 10% RBCs, fibrin/platelets and WBCs, 
respectively.10 Note the heterogeneous distribution of components, with 
distinct deposits of RBCs and fibrin/platelets arranged throughout the 
thrombus. 
With the advent of endovascular therapy greatly expanding the number of 
thrombi available for histological analysis, recent years have seen a dramatic 
increase in the number of studies examining the clinical implications of 




studies examining the relationship between thrombus composition and stroke 
etiology are shown in the table below: 
Table 1-1: Studies assessing the relationship between ischemic stroke 








Differences between   
CE – LAA thrombi* 
Marder66 2006 25 Qualitative 
categorization 
None 
Liebeskind67 2011 50 Semiautomated 
quantification 
None 
Sato68 2012 17† Semiautomated 
quantification 
CE: ↑RBC; LAA: ↑fibrin 
Boekh-
Behrens69 




Niesten70 2014 22 Visual 
quantification 
LAA: ↑RBC 
Sallustio71 2014 28 Qualitative 
categorization 
None 
Kim72 2015 37 Semiautomated 
quantification 
CE: ↑RBC; LAA: ↑fibrin 
Simons73 2015 40 Qualitative 
categorization 
None 
Ahn11 2016 36 Semiautomated 
quantification 
CE: ↑fibrin; LAA: ↑RBC 
Boeckh-
Behrens8 
2016 137 Semiautomated 
quantification  
CE: ↑fibrin/platelet,‡ 
↑WBC; LAA: ↑RBC 
Sporns10 2017 187 Semiautomated 
quantification 
CE: ↑fibrin/platelet,‡ 
↑WBC; LAA: ↑RBC 
Maekawa74 2018 43 Semiautomated 
quantification 
CE: ↑fibrin; LAA: ↑RBC 
Fitzgerald75 2019 105 Semiautomated 
quantification 
LAA: ↑platelet 
*Significant difference in thrombus area (%) between CE and LAA subtypes 
(p < 0.05); †Thrombi collected at autopsy; ‡Fibrin and platelets not 
differentiated in examination. CE, cardioembolism; LAA, large artery 




Despite the lack of consensus, methodological differences in the approach of 
these histological studies are instructive. Of note is that the majority (3/4) of 
studies finding no difference in thrombus composition between subtypes 
performed only qualitative classification of thrombi (categorized into “fibrin 
enriched,” “serpentine,” “erythrocytic”,  “layered” etc.), rather than employing 
some form of automated quantification of each component’s proportion. 
Among those that did perform quantitative assessment, the trends of early 
studies indicating CE thrombi having a higher proportion of RBCs directly 
oppose those of more recent studies indicating a higher proportion of fibrin, 
and less RBCs, in that same subtype. This shift could be explained by 
improvement in endovascular therapy devices and general operator 
experience increasing the proportion of thrombi retrieved as the therapy 
became more widespread. Early studies also tended to have smaller sample 
sizes than more recent ones. The consensus within recent studies suggests 
that a lower RBC and higher fibrin proportion is expected in thrombi caused 
by CE compared to those caused by LAA. It is worth noting that all studies in 
general found a trend of higher RBC levels in thrombi with low fibrin 
content, and vice-verse, indicating that these components are inversely 
related and are the principle sources of variation within stroke thrombus 
composition. 
Beyond the primary thrombus components, a few studies have identified the 
presence of lipid45,76 or calcium77,78 within thrombi and drawn relations to 
etiology. Lipid was found only in thrombi derived from LAA, while calcium 
was found only in thrombi derived from LAA or following an invasive cardiac 
procedure (suggesting disruption of a calcified cardiac valve), indicating that 
the presence of either of these components may be directly predictive of LAA 
stroke etiology in the absence of a preceding surgical procedure. 
There is strong evidence to support that thrombus composition may be a 




analysis is an involved process and can only be completed for patients in 
which a thrombus is retrieved, making it inappropriate for wide use within 
clinical care. Only 30-40% of ischemic stroke patients present with an 
occlusion large enough for endovascular therapy to be feasible, and just 25% 
of these patients are ultimately eligible for the therapy.79,80 Within these 
eligible patients 80% will have thrombi retrieved, meaning only 7% of 
ischemic stroke patients overall have thrombi available for histological 
study.81 Medical imaging offers the potential to noninvasively infer thrombus 
properties regardless of retrievability including but not limited to thrombus 
composition, however it presents its own unique set of challenges. The 
following section examines past attempts to leverage medical imaging to 
predict ischemic stroke thrombus composition and etiology, as well as the 
limitations associated with each technique. 
 
1.6 Imaging inference of thrombus composition and 
etiology 
Both MR and CT imaging are capable of assessing thrombus RBC content via 
their sensitivity to iron within the hemoglobin molecule. A number of 
previous studies have used qualitative MR or CT imaging signs to 
characterize thrombi and have demonstrated an association with RBC 
content. However, these signs have collectively proven unable to predict 
stroke etiology. With MR imaging, sensitivity to RBC oxygenation may 
confound qualitative predictions; quantitative MR approaches including R2* 
and quantitative susceptibility mapping may provide a basis to assess RBC 
content independent of oxygenation. However, typical statistical measures 




prediction, and more advanced techniques that account for intra-thrombus 
heterogeneity may be required. 
Coincident with stroke thrombus histological studies, medical imaging 
studies have been performed examining the relationship between thrombus 
imaging properties, composition and etiology. Both MR and CT imaging are 
sensitive to the iron atoms inside RBC hemoglobin, allowing non-invasive 
interrogation of RBC content.82,83 Qualitative and quantitative imaging 
characterization techniques have been developed and are described in the 
following subsections. 
1.6.1 Qualitative thrombus MR characterization 
In MR imaging, the hemoglobin iron atom possesses a high magnetic 
susceptibility which causes local field inhomogeneity, spin dephasing and 
ultimately signal loss. Importantly, this effect occurs only when hemoglobin 
is not bound to oxygen; this increases MR sensitivity to stroke thrombi 
relative to circulating blood, as tissue ischemia leads to reduced oxygen 
content in thrombi relative to oxygenated arterial blood.82 The presentation of 
a dark signal void resultant from deoxyhemoglobin within a stroke thrombus 
on gradient echo (GRE) imaging is referred to as a susceptibility vessel sign 
(SVS) (Figure 1-6).84 
In non-contrast CT imaging, iron’s high electron density leads to elevated 
photon attenuation relative to tissue, resulting in higher signal. CT signal 
intensity is measured in Hounsfield units (HU), and RBC content has been 
correlated to CT HU values in blood clots in vitro.85 However, unlike MR 
imaging, CT’s sensitivity to hemoglobin is independent of RBC oxygenation 
state, and it is therefore equally sensitive to iron inside thrombi as in 
circulating blood, resulting in a lower relative sensitivity to stroke thrombi 




non-contrast CT imaging is referred to as a hyperdense artery sign (HDAS) 
(Figure 1-6).87 Numerous studies have demonstrated a relationship between 
the presence of both the SVS and HDAS and stroke thrombus RBC 
content.67,88,89 
     
Figure 1-6: Neurological MR (left) and CT (right) images of stroke patients 
demonstrating qualitative thrombus imaging signs; SVS and HDAS, 
respectively. Figures from Liebeskind et al., reproduced with permission.67 
A number of studies have employed these qualitative imaging signs to search 
for a relationship with stroke etiology.90-92 While certain studies have derived 
significant associations, with most linking positive imaging signs to CE 
stroke, a recent meta-analysis of these studies found no statistically 
significant relationship overall between either SVS or HDAS and stroke 
etiology.93 These qualitative imaging assessments are limited by their ability 
to provide only binary information, and have demonstrated issues with intra-
observer and intra-scanner variability.94 Quantitative MR imaging methods 
have been investigated as a means to provide more advanced imaging 
characterization of stroke thrombi, while reducing reliance on individual 
interpretation. The quantitative MR metrics employed for thrombus 
characterization in this thesis include effective transverse relaxation time 




1.6.2 Effective transverse relaxation time (R2*) 
Disruption of the main MR magnetic field (B0) homogeneity by RBC 
deoxyhemoglobin leads to transverse signal dephasing and signal loss. This 
effect is quantifiable by measurement of the rate of signal loss in a signal 
decay curve, a plot of voxel magnitude values obtained across multiple echo 
times. In GRE imaging the signal decay rate corresponds inversely to the 
effective transverse relaxation time, known as R2* (=1/T2*), and is commonly 
derived through an exponential fit of the signal decay curve (Figure 1-7). 
 
Figure 1-7: Example signal decay curve with an exponential curve fit. Higher 
R2* values correspond to more rapidly decaying signal. 
While straightforward to perform, the exponential fit technique can lead to 
erroneous R2* values in voxels with very rapid signal decay, and the observed 
signal evolution can be influenced by several other factors including 
underlying B0 inhomogeneity and the presence of fat tissue. Because of this, 
more advanced signal processing methods have been developed which model 
R2*, B0 inhomogeneity and fat fraction (FF) simultaneously, though accurate 
FF mapping was the primary focus of these techniques rather than R2*.95,96 
The B0-NICE method, developed in the Drangova lab, also models R2*, B0 




three.97 B0-NICE uses a non-iterative lookup table approach to R2* mapping 
which is less susceptible to underestimation of R2* values in voxels with rapid 
signal loss, and is the algorithm used to quantify thrombus R2* in this thesis. 
The B0-NICE FF maps were additionally used to assess thrombus lipid 
content. 
1.6.3 Quantitative susceptibility mapping 
The mechanism through which the deoxyhemoglobin iron atom disrupts the 
B0 field is through a bending of its magnetic field force lines, changing the 
strength of the field inside and around it (Figure 1-8). All materials interact 
with and alter magnetic field lines to some extent; the parameter that 
quantifies the degree of this alteration is known as magnetic susceptibility. 
Materials which increase the strength of the local field are known as 
paramagnetic while those that decrease it are known as diamagnetic. Water, 
the main component of human tissue, has a diamagnetic susceptibility 
of -9.04 ppm, while RBC deoxyhemoglobin is paramagnetic relative to water 
with a magnetic susceptibility of -5.61 ppm, commonly written as a 
+3.43 ppm relative shift.98 Oxyhemoglobin has a comparatively negligible -0.1 
ppm diamagnetic shift relative to water. 
 
Figure 1-8: A uniform magnetic field in the presence and absence of magnetic 
material. Paramagnetic materials have a positive magnetic susceptibility and 
attract magnetic lines of force, while diamagnetic materials have a negative 




A material’s magnetic susceptibility directly influences the strength of the 
magnetic field it observes in addition to those of the atoms surrounding it. 
While high intravoxel susceptibility variation leads to the signal loss 
quantifiable by R2* mapping, direct estimation of a material’s magnetic 
susceptibility is also possible through a technique known as quantitative 
susceptibility mapping. Background field contributions to local phase are first 
removed to produce a local frequency shift map which is converted to a QSM 
map through an inversion process involving deconvolution of the dipole 
kernel. This inversion process is ill-posed however in that certain regions of 
the dipole kernel are undefined, meaning there are an infinite number of 
potential inversion solutions. QSM algorithms overcome this by incorporating 
prior information into the inversion; strategies differ across the multitude of 
QSM algorithms that have been developed though enforcing spatial 
smoothness in the estimated QSM map through regularization is the typical 
added condition.99,100 One of the most widely used QSM algorithms, known as 
morphology enabled dipole inversion (MEDI), explicitly matches spatial 
gradients within input magnitude images to gradients in the estimated QSM 
map, penalizing the formation of streaking artifact edges that plague many 
QSM reconstructions.101 MEDI is the QSM algorithm used to analyze 
thrombus magnetic susceptibility in this thesis. 
1.6.4 Quantitative thrombus MR characterization 
Direct assessment of R2* and QSM from multi-echo GRE acquisitions has 
been previously performed on prepared blood clots in vitro and demonstrated 
sensitivity to both blood clot RBC content and oxygenation, as expected 
(example shown in Figure 1-9).102,103 However, no study has quantified these 
MR values on blood clots of simultaneously varied composition and 
oxygenation, meaning that any translation of the derived relationships to 
stroke thrombi will be confounded by the codependence of R2* and QSM on 




designed to bridge this gap by deriving a quantitative relationship between 
blood clot R2* and QSM that can be used to predict clot RBC content 
independent of oxygenation. 
 
Figure 1-9: MR R2* (A) and QSM (B) maps of a phantom containing pairs of 
deoxygenated blood clots prepared in vitro of 10-60% RBC content (yellow 
label) with the remainder being composed of fibrin and platelets. 
Assessment of the relationship between thrombus R2* and QSM and stroke 
etiology remains limited. A single study has been completed that found no 
significant difference in mean thrombus R2* between stroke etiologies.104 
These inconclusive findings may be the result of small sample size (only 4 
LAA thrombi studied), but may also be indicative of a more fundamental 
weakness. Traditionally, quantitative imaging studies have used a single 
imaging value or metric to represent an entire sample, while histological 
studies of stroke thrombi have consistently shown that they are 
heterogeneously composed, with varied concentrations of their components 
throughout their structure. Intrathrombus compositional heterogeneity is 
observable with quantitative MR maps (Figure 1-10), at the scale of the 
acquired image resolution, and as such more complex image analysis 
methods sensitive to thrombus texture and morphology may allow more 
effective characterization of stroke thrombi. The following section describes 




their potential to extract detailed intra-thrombus information from 
quantitative MR images for improved prediction of stroke thrombus 
composition and etiology. 
 
Figure 1-10: Example thrombus (A) H&E histology slide (RBCs stain red; 
fibrin/platelets stain pink) along with a corresponding slice of its (B) GRE 
magnitude (TE = 31 ms), (C) R2* and (D) QSM maps. MR images are shown 
in a coronal view, with the vertical scanning vial walls indicated with ► and 
the thrombus outlined in cyan. Agar fills the space below the thrombus and 
outside the vials. * indicates the RBC-rich body of the thrombus which has a 







1.7 Artificial intelligence and potential for advanced 
thrombus analysis 
Artificial intelligence is a powerful tool that may be able to retrieve a greater 
level of information from images of thrombi than traditional imaging metrics 
can provide, specifically by interpreting intra-thrombus texture and 
morphological information. Machine learning and deep learning are two 
fields within artificial intelligence that have seen rapid growth in recent 
years due to improved computing resources, as well as mounting proof of 
utility within the medical imaging field. Machine learning makes explicit use 
of imaging-derived texture features, while deep convolutional neural 
networks are capable of deriving their own abstract features from raw images 
as input. These complimentary techniques have each demonstrated capability 
for providing valuable information related to stroke, but have seen very little, 
if any, application towards the study of stroke thrombi. Evidence suggests 
that they are powerful tools which may allow for more accurate 
characterization of thrombi than that possible using traditional techniques. 
Artificial intelligence describes the use of machines to perform tasks 
normally considered to require human intelligence, such as visual perception, 
decision-making, or problem solving. In the context of medical imaging, 
artificial intelligence allows the extraction of rich sets of information from 
quantitative imaging data beyond simple statistical measures such as mean, 
variance, inter-quartile ratio etc., such as measures related to object texture 
and morphology. As mentioned in the previous section, there is histological 
justification for consideration of thrombus texture, given the heterogeneous 
composition of most stroke thrombi. As thrombus composition is known to be 
influenced by the environmental conditions under which they are formed, 
interpretation of intra-thrombus information may yield deeper insight into 




and fibrin interspersed between waves of RBCs, and outer shells of condensed 
fibrin and aggregated platelets, have each been hypothesized to relate to 
changes in blood flow and pressure as a thrombus forms.65,105 Subject to the 
resolution limits of the input, artificial intelligence algorithms may be able to 
interpret subtle thrombus texture or shape features which are informative of 
its formation, and in doing so may allow both a finer characterization of 
thrombus RBC content and better prediction of etiology. The following 
sections describe in more detail two important forms of artificial intelligence, 
machine and deep learning, and their respective properties suited for 
thrombus analysis. 
1.7.1 Machine learning 
A subset of artificial intelligence, know as machine learning, refers to the use 
of computer algorithms, which automatically improve through experience. 
Typically, machine learning is applied in the context of supervised learning 
for classification or regression problems, wherein a computer is trained on 
labelled data with the aim of deriving a model, which can accurately predict a 
desired class or value from new, unseen data. A vast array of machine 
learning algorithms have been developed; a recent, exhaustive review 
evaluated 179 algorithms within 17 different families (discriminant analysis, 
Bayesian, neural networks, support vector machines, decision trees, rule-
based classifiers, boosting, bagging, stacking, random forests, generalized 
linear models, nearest neighbours, partial least squares and principal 
component regression, logistic and multinomial regression, multiple adaptive 
regression splines and other methods) for performing classification on 121 
datasets.106 The review found the random forest classifier provided the best 
general performance and this algorithm will be described in further detail in 
this section, while neural networks will be described in the following section 




Random forests consist of an ensemble of decision trees, which are tree-like 
chains of ordered binary decision nodes designed to learn to deduce a desired 
output value from input features derived from the dataset (e.g. age, colour, 
price). Decision trees generate criteria at each node using the input features 
to create a binary logic model; the computer derives the tree that most 
accurately categorizes the training dataset to align with its desired outcome 
variable. A random forest is created from multiple decision trees each trained 
on a randomly sampled subset of the dataset. In doing so, random forests 
overcome the tendency for single decision trees to overfit to its training 
data.107 When forming predictions on unseen testing data, the result of each 
decision tree is utilized to ‘vote’ on the predicted class or value; the random 
forest outputs the most voted for class or average value for each observation 
within the dataset (Figure 1-11). 
 
Figure 1-11: Schematic diagram of the random forest classifier. 
Regardless of the algorithm used, machine learning is dependent on the 
quality of the input features for deriving a useful model capable of generating 




multiple independent predictors of the desired outcome variable; in practice, 
the independence and predictivity of each input feature is almost always 
unknown and consequently large initial feature sets are desirable. From this 
initial, unrefined feature set a process termed feature selection is performed 
to identify the subset of features most predictive of the outcome variable. 
Typically, some form of linear regression, wherein features are correlated to 
each other and to the outcome variable to identify the features which are 
most independent and predictive, is used. 
Within the field of medical imaging, the extraction of quantitative features 
from images is known as radiomics.108 Radiomics features can consist of 
relatively simple, first-order statistical descriptors such intensity, size or 
shape measurements, but these features don’t tend to provide information 
that isn’t already perceivable by a trained observer. In contrast, texture 
features, second-order descriptors, which quantify the statistical 
interrelationships between voxels, can identify trends and relationships 
imperceptible to the human eye. Texture features are calculated from 
statistical matrices, most typically those tabulating the co-occurrence of pairs 
of pixel values (gray level co-occurrence; example in Figure 1-12), or 
commonality of runs of a particular pixel value (gray level run length). A near 
endless amount of texture features may be generated from these matrices but 
the typical starting point are the Haralick texture features, the first set of 






Figure 1-12 Diagram showing an example of texture feature value calculation 
from a second-order statistical matrix. The total number of co-occurring pairs 
of pixels across one direction in an image is used to create a gray level co-
occurrence matrix (GLCM), whose normalized values are used for the 
calculation of texture feature values. Figure from Brynolfsson et al., 
reproduced with permission.110 
Machine learning algorithms applied to radiomics texture features extracted 
from medical images have shown utility in a wide array of pathologies, but 
have shown particular usefulness in the field of oncology. Texture features 
have been used to predict tumour phenotype, histological grade, metastasis, 
and patient outcome, using random forest classifiers and multivariate Cox 
regression models.111-114 Texture features have also demonstrated utility in 
stroke, where they have been used as input for machine learning algorithms 
to predict post-stroke impairment and detect lesions using support vector 
machine classifiers.115,116 Though currently limited in scope, research has 
been produced showing promise for texture features in thrombus analysis; 
two studies applied them to predict blood clot RBC content in vitro, with one 
study using decision trees and another directly correlating features to RBC 
content.117,118 Two studies have applied this technique to acute stroke 
thrombi, and showed ability to predict response to rtPA and endovascular 





Texture features quantify image heterogeneity, and despite promising results 
from algorithms applied to thrombus CT data, machine learning algorithms 
have not been previously applied to stroke thrombi for the prediction of 
etiology, a task where measures of intra-thrombus heterogeneity seem 
particularly suited. A study utilizing a random forest classifier on texture 
features derived from ex vivo MR images of acute ischemic stroke thrombi for 
etiology prediction is described in the 4th chapter of this thesis. The following 
section describes a subset of machine learning which has seen an explosion of 
interest in recent years following advancements in computing technology, 
deep learning, and the unique properties it possesses that make it a 
complementary tool to machine learning for thrombus characterization. To 
introduce the topic a description of the machine-learning algorithm that 
forms the nexus of deep learning, the neural network, is first given. 
1.7.2 Neural networks and deep learning 
Originally described by Frank Rosenblott in the 1950’s, the single layer 
perceptron was the earliest form of neural network; a modelling system 
designed to mimic the structure of neurons within the human brain.121 
Beginning with an input layer built of separate neurons for each input 
feature, the perceptron’s input neurons are fully connected to a hidden layer 
of neurons themselves connected to a binary output layer (Figure 1-13). 
Associated with each connection is a weight parameter that quantifies the 
level of influence each neuron has on the output of those it is connected to. In 
iteratively updating these weight parameters based on the difference 
between the desired and predicted output, a process known as network 
tuning, the perceptron learns to separate between two classes of data. A 
single layer perceptron is a binary linear predictor function, and is therefore 





Figure 1-13: Schematic diagram of the simple perceptron. Each connection 
between the input layers and the hidden layer nodes is associated with a 
tuneable weight parameter (wi). Each hidden layer node performs a weighted 
sum of all input features (Σi), which themselves are summed (Σj) by the 
output layer. The output is determined to be true or false based on a binary 
output function. 
From this relatively simple starting point, more complicated neural networks 
capable of performing drastically more complex operations have evolved, 
becoming known as deep neural networks. While there this is no formal 
definition specifying precisely when a neural network becomes complex 
enough to be considered ‘deep’, certain advancements made in neural 
network design since the perceptron was first described have today become 
their essential properties. The inclusion of more than one hidden layer has 
become the de facto defining property of deep networks, as it is necessary to 
allow non-linear separation of data classes and enables more complex feature 
extraction, while backpropagation allows for drastically more efficient 
network tuning by allowing information from the gradient of the error 
function at deeper levels to be reused by more superficial ones. Increasingly 




data, to the point that handpicked, predictive input features sets are no 
longer required and networks are capable of deriving their own predictive 
features from comparatively raw data. Modern improvements to computing 
resources and greater access to large datasets for training have, in recent 
years, enabled deep neural networks to become drastically more practical and 
powerful. 
Within the rapid expansion of the deep learning field over the past decade, 
deep learning networks designed to handle images in particular have risen in 
prominence. These networks are called deep convolutional neural networks 
(CNNs), as they use learnable convolutional filters, which extract 
increasingly more complex patterns and features from image data. In doing 
so, they learn to perform a mapping of high dimensional input data (image) to 
a desired output. Over the past few years, a number of tools were developed 
to improve CNN performance that have since become standard in modern 
implementations. Non-linear activation functions (typically rectified linear 
units (ReLu)) allow CNNs to learn features complex enough to effectively 
interpret high dimensional input. Pooling and padding allow a reduction or 
increase, respectively, in the dimensionality of the feature maps allowing 
greater network flexibility. Batch normalization is the process of normalizing 
the output of each activation layer and allows the network to learn more 
quickly and avoid divergence. Dropout is the random removal of certain 
output nodes, which regularizes the network, increasing generalizability and 
preventing overfitting. The structure of a typical modern CNN is depicted in 
Figure 1-14. Improvements in CNN design have greatly increased their 
capability, and spurred translation of the technique from traditional 
computer vision tasks such as character recognition,122 object detection123 and 





Figure 1-14: Architecture of a modern CNN. Three convolutional layers are 
separated by ReLu’s and max pooling and/or batch normalization functions, 
followed by a fully connected layer with dropout before the final output layer. 
CNNs have been used for a diverse array of medical imaging applications, 
ranging from detecting metastases in the brain to classifying ulcers in the 
feet.125,126 In the field of stroke imaging, interest has piqued in the use of 
CNNs for analysis of neurological stroke images, for the detection and 
segmentation of stroke lesions and identification of penumbral tissue, for 
example.127,128 The singular strength of deep neural networks comes from 
their ability to derive their own abstract features, making them particularly 
suited for problems where relevant imaging features are difficult to define. To 
this end, CNNs have been used to abstrusely predict stroke patient prognosis, 
ischemic tissue outcome, and stroke onset time.129-131 
Characterization of stroke thrombi is another area where relevant imaging 
features are challenging to define, and hence is suited to analysis by deep 
learning networks. The interaction between RBC content and oxygenation on 
quantitative MR imaging values is complex and may be difficult to capture 
with traditional machine learning texture features in the context of thrombus 
composition inference. Deep learning has not been previously applied towards 
the analysis of human stroke thrombi, and the application of a deep CNN for 
the prediction of acute stroke thrombus RBC content using ex vivo MR 





1.8 Thesis hypotheses and objectives 
Despite marked improvement in stroke diagnosis and treatment in recent 
years, acute ischemic stroke remains a major source of disability and 
mortality across the world. Improvement in any facet of stroke care is always 
desirable, but a particularly significant gap exists in the determination of 
stroke etiology, a critical characteristic necessary for optimal post-stroke 
management. Medical imaging is today a cornerstone of stroke care, but is 
underutilized relative to its potential to compensate for weaknesses in the 
current paradigm. Histological studies have identified compositional patterns 
that link stroke thrombi to its underlying etiology, and while medical 
imaging techniques have demonstrated a qualitative sensitivity to RBC 
content, they have been thus far unable to provide accurate, quantitative 
prediction of thrombus RBC content or etiology. The hypothesis of this thesis 
is that quantitative MR imaging, specifically that focused on R2* and QSM 
mapping, is capable of accurately characterizing ischemic stroke thrombus 
RBC content and etiology through the application of machine and deep 
learning image analysis algorithms. This thesis consists of 5 Chapters 
designed to explore and support this hypothesis, the 1st consisting of this 
introductory description of the field. 
In the 2nd chapter, an in vitro study is presented which consists of a cohort of 
blood clots prepared with varied RBC content and scanned serially over 6 
days as their oxygenation status evolves. The objective of this work was to 
demonstrate that MR R2* and QSM parameters are each sensitive to RBC 
content and may be used in conjunction to allow prediction of RBC content 
independent of oxygenation state. The second objective of this work was to 
show that QSM and fat fraction (FF) mapping are capable of detecting 




In the 3rd chapter, a deep learning study is presented which involves the use 
of a deep CNN trained to predict RBC content using ex vivo MR images of 
retrieved acute ischemic stroke thrombi. The objective of this work was to 
demonstrate that CNNs are capable of learning to accurately predict RBC 
content in human thrombi from R2* and QSM thrombus maps, and support 
the notion that further improvements in prediction accuracy are achievable 
with sufficient sample size and data augmentation. 
In the 4th chapter, a machine learning study is presented which utilizes 
radiomics texture features extracted from ex vivo MR images of retrieved 
acute ischemic stroke thrombi to predict stroke etiology using a random 
forest classifier. The objective of this work was to demonstrate that accurate 
prediction of stroke etiology is possible through machine learning analysis of 
texture features extracted from thrombus R2*, QSM and FF maps, and 
investigate whether predictions can be improved through the incorporation of 
clinical patient data. 
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Simultaneous R2* and QSM measurement 
enables differentiation of thrombus 
hematocrit and age: an in vitro study at 3T 
 
2.1 Introduction 
Recanalization has been established as the definitive treatment for acute 
ischemic stroke,1 however the efficacy of common fibrinolytic and 
endovascular thrombectomy therapies is influenced by underlying thrombus 
composition.2,3 Stroke thrombi consist principally of red blood cells, fibrin and 
platelets, though relative proportions vary widely.4 In certain cases, calcium 
or cholesterol crystals may be incorporated within, or even form the majority 
of, an embolic thrombus;5,6 calcium interferes with fibrinolytic therapy,7 and 
both calcium and cholesterol affect thrombus mechanical properties.6 
Thrombus age may also affect lysis rate and indicate underlying etiology.8,9 
Magnetic resonance imaging (MRI) has demonstrated utility in the detection 
and staging of ischemic stroke,10 but an evolving understanding of the 
implications of thrombus composition motivates the development of imaging-
based thrombus characterization methods, which offer to non-invasively aid 
decision-making in acute stroke treatment and support determination of the 
embolic source. 
 
Imaging-based characterization of thrombi in vivo has largely been achieved 




blooming artifact on MRI or a hyperdense sign on computed tomography 
(CT).11,12 Though shown to be correlated to red blood cell proportion, such 
signs have proven inconsistent when applied towards association with 
underlying thrombus etiology,13 may be mimicked by the appearance of 
calcium14 and are insensitive to lipidic components. Quantitative MRI 
characterization methods utilizing diffusion or relaxation parameters have 
been successfully applied in preclinical models, but require lengthy scan 
times that are prohibitive in the clinic.15,16 Relaxation and quantitative 
susceptibility mapping (QSM) parameters have been measured for 
experimental blood clots in vitro,17,18 but did not include calcified or lipidic 
components and either compared multiple clots of different composition at 
one time or measured changes in a single clot over time. Because clinical 
thrombi vary in both composition and age, and each affects MR 
characteristics, both aspects must be considered if knowledge gained from in 
vitro characterization is to be extended to clinical application. 
 
Three-dimensional (3D) multi-echo gradient echo (GRE) acquisitions offer an 
opportunity to derive multiple quantitative imaging parameters in the form 
of quantitative maps from a single scan. The acquisition of multiple early 
echoes at various fat-water phase shifts allows for simultaneous proton-
density fat fraction (FF), R2* and B0 mapping through Dixon MRI post-
processing,19 while the acquisition of multiple echoes at late echo times is 
required for sufficient susceptibility weighting to perform QSM mapping.20 
Recently, a novel multi-echo GRE acquisition and analysis approach has 
combined an early, short-echo-spacing echo train (to enable Dixon MRI) with 
a large-echo-spacing echo train (to capture susceptibility variation and 
additional R2* information).21 Together, the post-processing algorithms and 
dual-echo-train GRE acquisition have the potential to provide multiple 
quantitative imaging parameters (FF, R2*, B0, QSM) suitable for 




examine the ability of R2*, QSM and FF values to characterize blood clot of 
varying hematocrit formed in vitro, some containing calcified and lipidic 
components, across an age range relevant to thrombi causing stroke. 
Specifically, we quantified R2* and QSM values of in vitro clot throughout 
ageing up to 6 days, examined the ability of the derived values to 
discriminate between various clot hematocrit and age, and finally assessed 
the ability to predict clot hematocrit and age from measured R2* and QSM 
values. Additionally, we compared the ability of standard clinical MRI 
thrombus assessment techniques (i.e. late-echo GRE magnitude) to R2*, QSM 
and FF maps for detecting calcified and lipidic components within clots of 
various hematocrit and age. 
 
2.2 Materials and methods 
2.2.1 Phantom preparation  
Thrombus phantoms were constructed using arterial porcine blood collected 
from a local abattoir and anti-coagulated with 0.109 M buffered sodium 
citrate (Medicago AB; Danmark, Sweden) in a 1:9 ratio. The anti-coagulated 
blood was centrifuged at 300 g for 10 minutes, the supernatant plasma was 
extracted and spun again at 300 g for 10 minutes to derive platelet-rich and 
platelet-poor plasma (PRP and PPP, respectively). Separate whole blood 
samples were spun at 775 g for 15 minutes to isolate red blood cells (RBCs). 
Blood samples of controlled hematocrit (10, 20, 30, 50, 40 and 60%) were 
prepared by mixing RBCs and PRP; two 5 mL samples of each hematocrit 
were placed inside 1 cm diameter polystyrene vials (chosen to have a minimal 
effect on QSM, <0.005 ppm shifts observed in water samples). Antibiotic 
(100X stock, Gibco Antibiotic-Antimycotic; Thermo Fisher Scientific; 




Chemicals; Georgetown, Canada) solutions were added to each sample 
achieving final dilutions of 1/100 and 1/45, respectively. Finally, clotting was 
induced by thromboplastin (Thermo Fisher Scientific; Waltham, MA) at a 
1/3000 final dilution. To mitigate clot retraction, clots were left undisturbed 
in the vials throughout the experiment. The time at which thromboplastin 
was added was considered to be the time of clot formation (t = 0). All clot vials 
were placed vertically into a preformed agar-filled container (3.5% agar, 8% 
glycerol, 2% formalin solution (neutral buffered, 10%)); samples were 
arranged concentrically within the phantom, and a vial containing peanut oil 
was placed in its centre to act as a control sample during FF mapping. The 
phantom was kept in a 37 °C water bath between scans to replicate biological 
conditions for clot ageing and will be referred to as the ‘blood-only’ thrombus 
phantom. 
To emulate clinical thrombi containing lipid, a separate thrombus phantom 
was prepared using identical methodology (hematocrit of 0, 20, 40 and 60%) 
but a piece of lard (~2.5 mm cube; local abattoir) was added to each of the 
blood samples (2 mL) immediately following the injection of thromboplastin. 
In this case the samples were left to coagulate at room temperature for one 
hour following thromboplastin injection, at which point 3 mL of PPP was 
added to fill the remaining air space above the formed multi-component clots 
within each vial. A sample containing a whole-blood clot (approximately 30% 
hematocrit) with an added piece of agar containing 5M calcium carbonate to 
simulate the presence of calcified tissue14 was also prepared. 
2.2.2 Image acquisition 
All imaging experiments were performed on a 3.0 T whole-body MRI scanner 
(GE 750, GE Medical Systems, Milwaukee, WI) using a 32-channel receive 
head coil. B0 and B1 shimming were performed prior to each imaging session. 




for clinical imaging in vivo; the sequence includes two 5-echo trains: the first 
train was optimized for chemical shift imaging (first echo time (TE) = 3.20 
ms, echo spacing = 1.46 ms); the second train was optimized to highlight 
susceptibility-related contrast at the level commonly observed within human 
brain in vivo (first TE = 16.75 ms, echo spacing = 7.15 ms). The remaining 
scan parameters were repetition time = 47.6 ms, bandwidth = 142.86 kHz, 
flip angle = 10°; field of view = 18 cm; matrix size = 192 × 192 × 42, for a final 
voxel dimension of 0.94 × 0.94 × 1.0 mm3. Bipolar readout enabled the in-and-
out of phase fat/water acquisition during the first echo train. No acceleration 
or averaging was used; the total acquisition time was 6 minutes 28 seconds. 
All phantoms were scanned in the coronal plane, with the vials aligned 
perpendicular to B0; clots were thus kept vertical throughout the experiment, 
limiting retraction and the introduction of air bubbles. The blood-only 
thrombus phantom was initially scanned every 15 minutes without 
repositioning from 30 minutes to 6 hours to investigate the MRI properties of 
acute thrombi; scans were then acquired at 22 and 26 hours and 2, 3 and 6 
days post clotting to represent chronic thrombus. The thrombus phantom 
containing lard was scanned at 3, 7 and 18 hours, then daily for one week; 
the calcium-containing clot was scanned at 2 hours and at 2 days post 
clotting. 
2.2.3 Image reconstruction and multi-parameter mapping 
Image reconstruction and multi-parameter map generation were performed 
in Matlab (Matlab 8 R2015a; Mathworks, Natick, MA). Raw image data were 
reconstructed off-line using the Orchestra Software Development Kit (GE 
Healthcare; Milwaukee, WI). Complex channel combination was performed 
using singular value decomposition and phase errors resulting from the 
bipolar acquisition were removed.21 Fat fraction, B0 and R2* maps were 




utilizes magnitude data processed independently to generate FF and R2* 
estimate maps, unwrapped phase data to generate initial phase-based B0 and 
FF maps, and then uses the derived magnitude-based FF map to correct for 
phase errors existing in phase-based B0 and FF maps to generate the final B0 
and FF maps. The algorithm was used with the first 5 acquired echoes to 
produce FF and B0 maps, and all 10 echoes for the generation of R2* maps. 
QSM maps were generated using the MEDI QSM algorithm20 implemented 
on all 10 echoes of the channel-combined complex data, with the λ 
regularization parameter set to 1000 and maximum iterations set to 10. The 
Laplacian boundary value method was used for background field removal, 
with tolerance, depth and peel set to 0.005, -1 and 0, respectively. 
The performance of the reconstruction and mapping algorithms described 
above was evaluated using a calibration phantom with known FF, QSM and 
R2*. Details pertaining to calibration phantom fabrication, analysis, and 
associated results are presented in Supplementary Material. 
2.2.4 Image analysis 
Segmentation of the blood-only clots and blood-only regions of clots 
containing lard or calcium was completed by using cylindrical regions of 
interest (ROIs) (~7-mm diameter and ~10-mm tall) to derive sample mean 
and standard deviation values for all measured parameters; care was taken 
to position ROIs to contain only clotted blood and exclude added lard or 
calcium when present, as well as slices showing clot retraction. The calcium 
and lard were segmented via thresholding applied within the clot on QSM 
and FF maps, respectively; the threshold for FF was 0.5 and that for QSM 






2.2.5 Data analysis 
The ability of simultaneously measured R2* and QSM values to estimate the 
age and hematocrit of the clots was evaluated. Clots aged 6 hours were 
considered acute and those aged >6 hours were considered chronic. Receiver 
operator characteristic (ROC) analysis was performed to derive the R2* and 
QSM thresholds that optimally differentiate acute from chronic clots. To 
estimate hematocrit in acute clots, linear regression was applied to determine 
the relationship between hematocrit and QSM values, while for chronic clots 
hematocrit was fitted as a decaying exponential function of the R2*/QSM 
ratio; all fitting was performed using data from six of the twelve clots (one 
from each pair, of each hematocrit). The remaining six clots were used to 
evaluate the performance of the derived relationships to predict hematocrit in 
both acute and chronic states. All data analysis was performed using 
GraphPad Prism (v7.0; GraphPad Software, La Jolla, CA).  
 
2.3 Results 
2.3.1 Acute clot (6 hours) 
Figure 2-1 illustrates representative R2* and QSM maps and values derived 
from the blood-only thrombus phantom in the acute phase (i.e. first 6 hours 
post clotting). R2* increased with hematocrit but was nearly identical for the 
40-60% hematocrit clots (Figure 2-1C). A small, consistent increase in R2* was 
observed over time, with the slope increasing markedly between the 10% and 
20% clots (0.04 s-1hr-1 and 0.31 s-1hr-1, respectively); the slope plateaued at 
approximately 0.5 s-1hr-1 for the 40-60% hematocrit clots. Over the six-hour 
period clot QSM values remained constant (Figure 2-1D) and were linearly 




clots of the same composition at the six-hour time point is shown in Figures 
2-1E and F; similar consistency was observed at all acute time points, as 
expected. 
 
Figure 2-1: Acute blood clot relaxation and magnetic susceptibility 
quantification; shown are the central coronal slices of the (A) R2* [0 s-1, 80 s-1] 
and (B) QSM [-0.5 ppm, 0.5 ppm] maps for the blood-only thrombus phantom 
at 6 hours post clotting. The mean (C) R2* and (D) QSM values of an 
individual clot from each pair (10 to 60% hematocrit) are shown over the first 
6 hours post clotting; error bars were omitted for clarity. The mean and 
standard deviation of each clot pair with the same nominal hematocrit at the 
six hour time point are shown for (E) R2* and (F) QSM, demonstrating 
reproducibility. 
2.3.2 Chronic clot (>6 hours) 
The effects of chronic ageing (up to six days) on mean R2* and QSM values are 




1hr-1 for 40-60% hematocrit), before reaching a plateau after the 44 hour scan 
(Figure 2-2A). High hematocrit clots (over 40%) were indistinguishable from 
each other on the basis of R2*. Measured QSM increased in proportion to clot 
hematocrit over the first 44 hours and remained constant for the remainder 
of the experiment (Figure 2-2B). Unlike R2*, QSM was linearly related to clot 
hematocrit at all time points. Because both R2* and QSM changed over time, 
neither could be used alone to infer hematocrit in a thrombus of unknown 
age. A plot of R2* against QSM (Figure 2-2C), demonstrates a linear 
relationship with a unique slope at all hematocrits – decreasing from 325 to 
173 s-1ppm-1 as hematocrit increased from 10 to 60%, suggesting that 
hematocrit may be estimated from the R2*/QSM ratio. 
2.3.3 Acute and chronic clot differentiation 
The receiver-operating-characteristic analysis used to derive R2* and QSM 
thresholds that differentiate between acute and chronic clots yielded a QSM 
threshold of 0.165 ppm with a corresponding sensitivity and specificity of 85 
and 92%, respectively; the area under the curve (AUC) was 0.932 (95% CI 
0.892 to 0.972; p<0.0001). All acute clots had mean R2* below 22 s-1, while 
chronic clots had an R2* greater than 24 s-1 (i.e. 100% sensitivity and 
specificity; AUC =1). 
2.3.4 Clot hematocrit prediction 
The ability to use measured R2* and QSM to predict clot hematocrit at any 
age is demonstrated in Figure 2-3. For acute clots, Figure 2-3A shows that 
hematocrit can be estimated from QSM (HCT = 260*QSM + 9%; where HCT 
is the hematocrit percentage; R2 = 0.97). For chronic clots, Figure 2-3B shows 
that hematocrit can be estimated from the R2*/QSM ratio (HCT = 125.3*exp(-
0.007*R2*/QSM) + 4.2%; R2 = 0.77). Evaluation of the ability to predict clot 




mean absolute error of 4.9 ± 3.1% for the acute clots and 8.3 ± 5.4% for the 
chronic clots. 
 
Figure 2-2: Blood clot R2* and QSM of chronic clots throughout ageing; (A) R2* 
and (B) QSM values of blood-only clots from 6 up to 144 hours post clotting 
(the 6-hr time point is included in order to relate these results to those of the 
acute clots of Figure 2-1). Plotted are mean values of individual clots; 
standard deviation error bars of only the 60% hematocrit clots are shown for 
clarity, error bars for QSM were smaller than the symbols. (C) Scatter plot 






Figure 2-3: Relationship between hematocrit and measured quantitative 
imaging values in acute (≤6 hours) and chronic (>6 hours) clot. (A) Acute clot 
hematocrit can be estimated linearly from measured QSM values, while (B) 
chronic clot hematocrit can be estimated from an exponential relation of the 
ratio of R2* / QSM. Shown are data points from the same 6 clots (one from 






2.3.5 Identification of lipid and calcifications within clot 
Representative images from the lard clot phantom are displayed in Figure 2-
4. Results from two time points are shown – the 7-hour time point 
representing acute (Figures 2-4A, C) and the 4-day time point representing 
chronic clot (Figures 2-4B, D). The magnitude images (Figures 2-4A, B) are 
representative of GRE acquisitions commonly used for thrombus 
characterization. As expected, the TE=4.2 ms magnitude images show no 
ability to differentiate hematocrit, while the TE=31 ms magnitude images 
demonstrate a decrease in signal intensity with increasing hematocrit in the 
chronic clot (Figure 2-4B). However, this signal loss eliminates contrast 
between the clot and lard. The quantitative R2*, QSM and FF maps (Figures 
2-4C, D) demonstrate that differentiation between clot and lipid components 
is possible independent of the clot age or hematocrit; the lard is clearly 
distinguishable based on its high FF (mean: 0.78 ± 0.02). Similar results are 
observed in the clot containing agar with 5M calcium carbonate (Figure 2-5), 
where the calcium is readily distinguishable from clot due to its diamagnetic 
QSM value (mean: -0.34 ± 0.08 ppm) at both two hours and two days post 







Figure 2-4: Regions (1.2 × 1.4 mm) from representative sagittal slices through 
select clots (0, 20, 40% hematocrit) in the lard clot phantom demonstrating 
discriminability of the added component; shown are early and late echo 
magnitude images of clots within the phantom at (A) 7 hours and (B) 4 days 
post clotting. These images represent the current standard technique for 
thrombus characterization; lard is either visible within clot as a nondescript 
area of low signal (red arrows) or is undetectable because of signal void 
produced by chronic clot (B; 20 and 40% clots at 31 ms). R2*, QSM and fat 
fraction (FF) maps of the phantom are shown at (C) 7 hours and (D) 4 days 
post clotting. Lipid is readily distinguishable from clot by its elevated FF 
value in clots of all hematocrits whether acute or chronic. Noticeable 
differences in R2* and QSM values between clots of different hematocrit can 
also be observed in the chronic clots in (D). 
 
Figure 2-5: Regions (1.2 × 1.4 mm) from representative sagittal slices through 
a single whole-blood clot with an added piece of agar containing 5M calcium 
carbonate (red arrows); shown are early and late echo magnitude images at 




added to clot, calcium carbonate shows low signal on early and late 
magnitude images, but differs with high R2*, low QSM and low FF values. 
The calcium carbonate is definitively identified within both acute and chronic 
clot by its negative QSM values (black in the QSM maps of (B)). 
 
2.4 Discussion 
This study demonstrates the use of R2*, QSM and FF maps to characterize 
and differentiate blood clot based on hematocrit and age, as well as to 
identify calcified and lipidic components when present. Such quantitative 
information provides a non-invasive tool to characterize thrombus 
composition, and to potentially inform decisions in the management and 
treatment of acute ischemic stroke. The hematocrit of acute clot (≤6 hours) 
could be determined directly from QSM, but as the clots aged beyond the 6-
hour time point, knowledge of the relationship between R2* and QSM was 
required to estimate hematocrit. Calcified and lipidic components were easily 
identifiable in clot of any hematocrit and age through QSM and FF mapping, 
respectively. 
 
A blood-only thrombus phantom was scanned serially every 15 minutes over 
the initial 6 hours post clot formation, and then intermittently thereafter for 
up to 6 days. The 6-hour timeframe for more rigorous examination was 
chosen because it is the commonly accepted treatment window for 
thrombolytic and endovascular therapies for acute ischemic stroke;22 clots 
examined over this period therefore give insight into the parameter values 
expected in spontaneously formed, immediately occluding thrombi, as well as 
how these values may evolve over the treatment window. R2* and QSM 
values showed clear differences between the acute clots of different 
hematocrit, indicating that even newly formed (and thus well-oxygenated) 




susceptibility. In terms of the change in values over the 6-hour time period, 
only a small increasing trend was observed in R2* while no trend was 
observed in QSM values, implying little change in hemoglobin oxygenation 
status. This is significant because it suggests that 6 hours may not be enough 
time for thrombi to deoxygenate under ischemic conditions in vivo, and 
therefore that thrombi that are deoxygenated upon clinical presentation 
(indicated by the presence of a blooming artifact) have become so only after 
considerable ageing at the site of thrombus formation, prior to embolization. 
 
Observation of these same clots over the next 6 days of ageing, in contrast, 
demonstrated considerable changes over the course of the experiment. Both 
R2* and QSM values of clots increased in proportion to hematocrit over time, 
reaching a plateau after 44 hours. Increasing R2* and QSM values within the 
first few days of in vitro clot formation have been observed previously.17,18 
RBC homeostasis is maintained through the metabolism of glucose;23 the 
limited supply of naturally present glucose in vitro inevitably results in the 
oxidative denaturation of oxyhemoglobin to paramagnetic deoxy- and 
methemoglobin forms,24 increasing QSM values, and consequently 
heightening local field inhomogeneity and thereby increasing R2*. The delay 
from clotting to when the rapid increase in R2* and QSM values was observed 
is likely linked to the time taken for RBCs to exhaust the local glucose 
supply. Because the clot R2* increase is driven primarily by a change in 
magnetic susceptibility inhomogeneity, we would additionally expect the clots 
with a similar heterogeneity of components (hematocrit between 40 to 60% in 
this study) to demonstrate similar R2* values. Indeed, R2* values of the 40, 50 
and 60% clots were comparable throughout the experiment, matching 
previous measurements of deoxygenated blood.25 The observed decrease in 
R2* observed at the 140 hour time point is likely due to a drop in R2 that 





The quantitative imaging values derived in this in vitro study strongly 
suggest that simultaneous measurement of R2* and QSM could be used to 
infer hematocrit and age in clinical thrombi. Our results suggest that a 
thrombus presenting with R2* and QSM values below 22 s-1 and 0.165 ppm, 
respectively, can be considered to be acutely formed, and for these thrombi 
hematocrit can be inferred directly from QSM. When R2* or QSM values are 
above these thresholds, the thrombus can be assumed to be chronic and R2* or 
QSM values alone will not be able to discriminate between a moderately aged 
thrombus of high hematocrit and one of advanced aged with low hematocrit. 
This study suggests that once a thrombus is identified as chronic, the 
R2*/QSM ratio can be used to estimate hematocrit regardless of age. We 
tested a number of parametric fitting methods to derive an equation relating 
imaging values to hematocrit, including fitting to exponential and power 
functions, as well as multiple linear regression; exponential fitting was 
chosen because it provided the best performance, however no underlying 
model was considered to justify this choice and it may not represent the best 
possible method. Our hematocrit prediction accuracy of better than 10% 
suggests that even clots of hematocrit between 40-60%, which showed similar 
R2*, varied enough in their QS values to be differentiable by the R2*/QSM 
ratio. 
 
Of course, the derived values and relationships in this study of in vitro clots 
may not be directly applicable to the clinic and must be validated in excised 
human thrombi. Validation of the R2* and QSM thresholds for differentiating 
between acute and chronic thrombus also needs to be performed in vivo, 
however this is difficult to achieve as thrombus age is rarely known. It must 
be further stressed that the age threshold of 6 hours defined here to 
differentiate acute and chronic clot is unlikely to directly correspond to the 
time period in which similar changes occur within thrombus imaging values 




between subjects. Nonetheless, the evidence provided here strongly suggests 
that R2* and QSM, measured simultaneously, are able to act as imaging 
biomarkers that can identify thrombus age and hematocrit. 
 
Additional clot phantoms were constructed to investigate the ability of the 
quantitative maps to distinguish calcified and lipidic components within clots 
of varied hematocrit and age, and to compare that to the ability of current 
thrombus characterization methods. For acute clot, GRE magnitude images 
have the ability to detect the calcified or lipidic components, but both give an 
identical, low signal appearance; the GRE images are also unable to 
discriminate between clots of different hematocrit. In contrast, lard shows 
elevated FF compared to all clots and to calcium, while calcium shows unique 
negative QSM values. In chronic clots, late-echo-magnitude images can 
roughly tell apart clots of low vs. high hematocrit by the extent and degree of 
signal loss, but this signal loss removes contrast between the clot and 
additional components, eliminating the possibility of their detection. Applied 
together, the quantitative R2*, QSM and FF maps distinguish between clots 
of different hematocrit, as expected, while also providing the ability to 
identify calcium and lipid components from the QSM and FF maps, 
respectively. 
 
Unavoidable imperfections of an in vitro clot phantom for representing 
thrombi should be considered as limitations for transferring our findings to 
future in vivo studies. Clots were formed statically through the addition of 
thromboplastin, which has been shown to yield clots that are more 
homogeneous than clinical thrombi,26 were assessed in a phantom that did 
not incorporate the effects of blood flow, and were larger (10 mm diameter) 
than those typically observed in vivo. During the first six hours, clots were 
kept at room temperature within the MRI bore, which may have affected 




selected to be directly translatable to in vivo head imaging, and hence were 
not optimized for in vitro samples. No histology was performed to confirm 
that initial sample hematocrit was maintained throughout the experiment; 
some retraction was observed in the 20 and 30% hematocrit clots and this 
could have affected their true hematocrit, and measured imaging values, as 
the experiment progressed. The lipid and calcium components do not 
perfectly mimic in vivo thrombus cholesterol and calcifications. Cholesterol 
within thromboemboli have been reported to consist of numerous small 
crystals rather than a singular mass.27 Similarly, thrombus calcifications, 
often derived from embolized calcifications within atherosclerotic plaque, are 
composed primarily of calcium apatite,28 which is slightly less diamagnetic 
than calcium carbonate and will therefore yield reduced QSM contrast.29 
Blood-related flow artifacts and signal contamination from the venous system 
may affect the quantitative maps in vivo, particularly for QSM processing,30 
but can be minimized through flow compensation and increasing spatial 
resolution.31 Variable flip angle turbo spin echo sequences have also been 
proposed as method for rapid, single-scan thrombus characterization,32 and 
while they possess advantages of inherent black blood properties and variable 
T1-weighting, these techniques provide only qualitative information and often 
require contrast administration.33 
 
2.5 Conclusion 
The 10-echo GRE sequence and post-processing algorithms used in this study 
generated accurate R2*, QSM and FF maps, which enabled quantitative 
characterization of blood clot including the ability to estimate hematocrit and 
age, while also distinguishing lipidic and calcified components. The protocol 
is readily translatable to the emergency clinic as all quantitative maps were 
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2.7 Supplementary material 
2.7.1 Methods 
A calibration phantom was constructed to validate derived fat fraction (FF), 
quantitative susceptibility mapping (QSM) and R2* maps, and included a 
range of fat-water emulsions stabilized with agar, and aqueous gadolinium 
(Gd) solutions. Samples with fat fractions of 0.1, 0.2 and 0.5 were prepared by 
dispersing appropriate amounts of peanut oil into water with 43 mmol/L 
sodium dodecyl sulfate (Sigma-Aldrich; St. Louis, MO). Samples were 
emulsified using a sonifier (Branson S-450; Branson Ultrasonics; Danbury, 
CT) for 2 minutes while heat was applied using a heat gun. Separately, a 4% 
agar solution (Sigma-Aldrich; St. Louis, MO) was prepared and kept at 70°C 
using a hot plate. The emulsified oil solution was added dropwise to the agar 
solution with the mixture being heated and under sonication. An equivalent 
volume of emulsified oil solution was added to the agar solution such that the 
final concentration of agar was 2% in all cases. Separately, aqueous 
Gadolinium solutions (Magnevist; Berlex Laboratories; Wayne, NJ) were 
prepared at 0.125, 0.25, 0.5, 1, 1.5, 2 and 2.5% of the raw (0.5 mmol/mL Gd) 
contrast agent, yielding magnetic susceptibility shifts of 0.20, 0.40, 0.81, 1.63, 
2.45, 3.26 and 4.08 ppm at room temperature.1 Control samples of water (FF 
= 0) and pure peanut oil (FF = 1) were also prepared. All samples were 
transferred into 1 cm diameter, 5 mL polystyrene vials and placed vertically 
inside an agar-filled container. 
The calibration phantom was scanned with the same 10-echo GRE sequence 
used for the thrombus phantoms. An additional scan was also performed 
using the spoiled gradient-echo version of the IDEAL sequence to provide an 
accepted-standard assessment of the fat fraction of the prepared samples.2 
IDEAL FF maps were reconstructed on the scanner. Parameters for this scan 




repetition time = 13.6 ms, bandwidth = 142.86 kHz, flip angle = 5°, field of 
view = 18 cm, matrix size = 160 x 160 x 20, slice thickness = 4 mm. No 
averaging was performed. 
Following reconstruction and multi-parametric map generation, 
segmentation of the FF calibration samples was accomplished by placing a 7-
mm diameter, 12-mm length cylinder across the middle slices of both the 10-
echo maps and the IDEAL FF maps. A 7-mm diameter circular cylindrical 
region of interest (ROI) drawn across the central slice of the QSM map was 
used for segmentation of the susceptibility calibration samples. Mean and 
standard deviation values of the segmented pixels were recorded. 
2.7.2 Results 
Representative slices from FF, QSM and R2* maps and sample values derived 
from the calibration phantoms are displayed in supplementary Figure 2-1. 
Agreement was observed between the mean fat fraction values of the FF 
calibration samples as determined by B0-NICE and IDEAL (supplementary 
Figure 2-1D), though a slight overestimation of the B0-NICE FF is present 
(max overestimation = 0.05) for the mixed fat-water emulsions as compared 
to the IDEAL FF. This discrepancy is likely due to the flip-angle-dependent 
T1 effect that biases scans with higher flip angles towards yielding larger FF 
estimates (FA: 5 and 10º for IDEAL and B0-NICE, respectively).3 A linear 
trend with a slope approaching unity (slope = 1.03, R2 = 0.99) was observed 
between the expected and measured susceptibility values for the QSM 
calibration samples (supplementary Figure 2-1E), indicating the QSM 
method can perform accurate quantification of susceptibility across a broad 
range of susceptibility shifts (up to 4.08 ppm). Lastly, a linear relationship 
was observed between B0-NICE R2* and Gd concentration up to 12.5 mmol/L 





Supplementary Figure 2-1: Central coronal slices of the (A) B0-NICE fat 
fraction (FF) [0, 1], (B) MEDI quantitative susceptibility mapping (QSM) [-
1.25 ppm, 3.25 ppm] and (c) B0-NICE R2* [0 s-1, 350 s-1] maps. For the FF 
phantom (A) the nominal fat fraction of each vial is identified; unlabeled vials 
contain both fat and Gadolinium (Gd) and were not analyzed. For the 
susceptibility phantom (B, C), labels show Gd concentration (mM); unlabeled 
vials contain oil/water emulsions. (D) B0-NICE FF plotted against FF 
measured using the IDEAL sequence; (E) measured QSM against expected 
sample susceptibility; (F) B0-NICE-derived R2* is plotted against Gd 
concentration. Error bars represent the standard deviation of all pixels 
within each region of interest. Note that the oil vial displays an artifactual 
diamagnetic susceptibility on the QSM map because of the varying fat-water 










1. de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility 
map reconstruction from MR phase data using bayesian regularization: 
validation and application to brain imaging. Magn Reson Med 
2010;63:194-206. 
2. Reeder SB, McKenzie CA, Pineda AR, et al. Water–fat separation with 
IDEAL gradient–echo imaging. J Magn Reson Imaging 2007;25:644-52. 
3. Liu C-Y, McKenzie CA, Yu H, et al. Fat quantification with IDEAL 
gradient echo imaging: correction of bias from T1 and noise. Magn 




























Quantitative prediction of stroke thrombus 
erythrocyte content from ex vivo 
multiparametric MRI using deep learning 
 
3.1 Introduction 
The desired outcome of acute ischemic stroke (AIS) treatment is to achieve 
rapid recanalization, and yet despite improvements in thrombolytic agents 
and reperfusion devices, successful recanalization is not achieved in 
approximately 25% of patients.1 Thrombus composition has emerged as a 
significant factor influencing the success of AIS treatment.2 Particularly, the 
proportion of thrombus erythrocyte (red blood cell (RBC)) content has been 
linked to the efficacy of both recombinant tissue plasminogen activator (rtPA) 
and endovascular thrombectomy (EVT) therapies.3,4 Non-invasive prediction 
of thrombus RBC content prior to acute treatment would provide a valuable 
tool for stroke interventionalists, and has been sought through medical 
imaging. 
The presence of qualitative susceptibility vessel and hyperdense artery signs 
in MR and CT imaging, respectively, have each demonstrated capability for 
characterizing RBC content categorically, distinguishing between groups 
such as RBC vs. fibrin-dominant.4,5 However, such signs have proven 
inconsistent in their predictions of thrombus amenability to rtPA and EVT 
therapies6 and have noted issues with inter-scanner variability.7 




mapping (QSM) values, or CT Hounsfield units have shown promise for more 
robust, quantitative prediction of RBC content,3,8,9 as well as for predicting 
efficacy of rtPA and EVT therapies.10,11 However, these techniques remain 
limited by their use of a single imaging value or metric to represent entire 
thrombi. Histological studies have consistently demonstrated that thrombi 
are heterogeneous and complex in structure,12 and that complexities such as 
the distribution of fibrin and RBC components have a material impact on 
treatment efficacy.13 
To account for these structural complexities, machine learning techniques 
have recently started being applied towards thrombus analysis. Past 
techniques generated models from MR or CT imaging texture features, and 
have demonstrated sensitivity to clot RBC content in vitro 14,15 as well as an 
ability to predict clinical features such as response to rtPA.16 Concerns linger 
however about the reproducibility of calculated texture futures and the 
generalizability of these techniques.17 Further still, machine learning 
techniques are limited by the need to initially handpick extractable features 
for study; the histomorphological basis underlying the distinguishing ability 
of imaging texture features is an ongoing area of research.18 
Deep learning neural networks provide a complimentary tool to machine 
learning techniques with the primary advantage being that featurization, the 
process of turning raw signal into a modellable predictor, is fully automated. 
Convolutional neural networks (CNNs) have been successfully applied 
towards medical imaging problems where relevant imaging features are 
difficult to define, such as for predicting brain age and aneurysm 
stability.19,20 CNNs have also demonstrated utility in AIS, in areas such as 
predicting ischemic tissue fate and thrombus detection.21,22 However, CNNs 
have not yet been applied towards analysis of the thrombus itself. In this 
study, we assess the capability of CNNs for prediction of stroke thrombus 




quantitative MR R2*, QSM maps as well as T2*-weighted gradient echo (GRE) 
images of ex vivo AIS thrombi retrieved by EVT, investigated the use of data 
augmentation techniques to improve network performance, and 
quantitatively assessed the accuracy of the trained CNN for numerical 
prediction of RBC content. 
The methods for prediction of RBC content directly from mean clot R2* and 
QSM, described in Chapter 2, were tested on the human thrombi included in 
this study but ultimately failed to produce accurate predictions. Thrombus 
RBC content was consistently underestimated and a Bland-Altman plot of 
these predictions is shown in this chapter’s supplementary material 
(supplementary Figure 3-1). More advanced image analysis techniques were 
necessitated, and deep learning was chosen because of its ability to interpret 
multiple image types simultaneously, a feature found to be important in 
Chapter 2 wherein the relationship between clot R2* and QSM was used to 
derive RBC predictions. 
 
3.2 Materials and methods 
3.2.1 Thrombus collection and storage  
Institutional research ethics board approval was obtained for this study. AIS 
patients who were treated with EVT at the local stroke centre were 
consecutively enrolled between the periods of February 2016 to November 
2017. Retrieved thrombi were stored and transferred to an attached 
institution for ex vivo MR imaging and histological analysis. Patients were 
excluded if insufficient thrombus material was retrieved for study (>2 mm in 
all dimensions) or if younger than 18 years old. Informed consent was 





A total of 109 thrombi were collected from 65 AIS patients. Thrombi were 
stored inside a 150 mL plastic jar containing a non-adherent pad (Telfa; 
Covidien, Mansfield, MA) wetted with heparinized saline to retain moisture. 
Those retrieved during the daytime were kept at room temperature and 
scanned within 6 hours of retrieval, otherwise thrombi were kept inside a 
refrigerator overnight until the following workday. It was observed that 
thrombi which had been placed in a fridge and stored overnight had 
significantly lower R2* and QSM values than those kept at room temperature 
(supplementary Figure 3-2). Due to this effect, only those stored at room 
temperature were histologically analyzed and included in the study; final 
sample size was 48 thrombi. Clinical details associated with each group of 
stored thrombi are listed in Table 3-1. 
 
 
Table 3-1: Clinical details of the patient cohort for each thrombus storage 
group 
Storage type Room temperature (n = 31) Refrigerator (n = 32)  
Age (mean ± SD) 67 ± 17 70 ± 12* 
Sex, female 14 (45%) 13 (43%)* 
Number of thrombi 48 61 
Etiology   
   Large artery atherosclerosis 6 (20%) 3 (9%) 
   Cardioembolism 21 (68%) 22 (69%) 
   Dissection 2 (6%) 1 (3%) 
   Undetermined 2 (6%) 6 (19%) 
Occlusion site   
   MCA 25 (81%) 27 (85%) 
   ICA 1 (3%) 3 (9%) 
   Vertebrobasilar 5 (16%) 2 (6%) 
EVT technique   
   Stent 26 (84%) 29 (91%) 
   Aspiration 5 (16%) 3 (9%) 
IV rtPA 15 (48%) 11 (34%) 
*n=2 missing data 
MCA, middle cerebral artery; ICA, internal carotid artery; IV rtPA, 




3.2.2 Ex vivo thrombus imaging 
Following storage, the retrieved thrombi were scanned inside 1 cm diameter 
polystyrene vials containing porcine plasma and vertically inserted into a 15-
cm diameter agar-filled container.8 A small agar plug was added to the 
bottom of the vials so that the thrombi sat flat on their surface. When more 
than one specimen was obtained from a single participant, thrombus pieces 
were scanned in individual tubes and analyzed separately. Scanning was 
performed at 3.0 T using a whole-body MRI scanner (GE 750; GE Medical 
Systems, Milwaukee, WI) with a 32-channel receive head coil. Scans were 
acquired using a 3D multi-echo bipolar GRE sequence designed for clinical 
imaging in vivo;23 the sequence includes two 5-echo trains: the first train was 
optimized for chemical shift imaging (first echo time (TE) = 3.20 ms, echo 
spacing = 1.46 ms); the second train was optimized to highlight susceptibility-
related contrast (first TE = 16.75 ms, echo spacing = 7.15 ms). The remaining 
scan parameters were repetition time = 47.6 ms, bandwidth = 142.86 kHz, 
flip angle = 10°; field of view = 18 cm; matrix size = 192 × 192 × 36, for a final 
voxel dimension of 0.94 × 0.94 × 1.0 mm3. Total acquisition time was 5 
minutes 33 seconds. Balanced steady-state gradient echo (FIESTA-C) images 
with identical resolution and bandwidth were also acquired to facilitate 
thrombus segmentation (TE = 3 ms, TR: 6.1 ms, flip angle: 40°, phase cycles = 
4, scan time = 2 min 47 sec). All scans were acquired in the coronal plane, 
with the phantom laying flat along the MR table and vials aligned 
perpendicular to B0. Thrombi sat horizontal relative to the long axis of the 
vials, and were also aligned perpendicular to B0. 
3.2.3 Image processing 
Image reconstruction was performed in Matlab (Matlab R2019a; Mathworks, 
Natick, MA) using the Orchestra Software Development Kit (GE Healthcare; 




value decomposition from which GRE magnitude images were derived. R2* 
and QSM maps were generated using the B0-NICE and MEDI QSM 
algorithms.24,25 Thrombi were segmented from the FIESTA-C images, which 
were inherently co-registered with the GRE sequence. Thrombus R2*, QSM 
and GRE magnitude pixel values were each separately z-score normalized 
according to distributions derived from all segmented thrombi. 
3.2.4 Histological analysis 
Immediately following imaging, thrombi were formalin fixed, embedded in 
paraffin and arranged for sectioning along the MR slice-encoding direction. 
Thrombi were sectioned at 5 μm thickness and stained with hematoxylin & 
eosin. The first 14 were sectioned in 4 evenly spaced regions throughout the 
thrombi (3 – 4 mm thick on average); it was observed that RBC content 
varied minimally between thrombus slices, concurring with the findings of 
Staessens et al.,26 so remaining thrombi were sectioned only once through the 
middle of each sample (supplementary Figure 3-3). Stained slides were 
scanned at ×40 magnification. The color segmentation plugin (EPFL, 
Lausanne, Switzerland) in ImageJ (National Institutes of Health, Bethesda, 
MD) with post-processing correction for outlying pixels in Matlab was used to 
quantify thrombus RBC percentage by area. 
3.2.5 Deep learning network 
3.2.5.1 Network architecture 
Using the acquired thrombus MR images, a convolutional neural network 
(CNN) was trained in Matlab to predict histological RBC content. Two-
dimensional slices of the segmented, normalized R2*, QSM and late echo GRE 
magnitude images (TE = 31 ms) were fed into the network as 3-channel RGB 
images; each image was 49 × 56 pixels in size. 188 segmented 3-channel slices 




assumed that all slices from a single thrombus had the same RBC content 
derived from histology. The network architecture – shown in the schematic 
illustration in Figure 3-1 – consisted of 2 repeated blocks of a convolutional 
layer (3×3, stride of 1, zero-padded), a rectified linear unit (ReLU) and an 
average-pooling layer (2×2, stride of 1), followed by a final convolutional layer 
and ReLU layer, a dropout layer and a fully connected layer with a single 
output connected to the regression layer. The number of feature channels for 
each of the convolutional layers was set to 16, 16, and 32, respectively. The 
Adam optimizer was used with an initial learning rate of 0.001; L2 
regularization was implemented with a λ of 0.01. Network parameter weights 
were trained by minimizing the half mean squared error using stochastic 
gradient decent. 
 
Figure 3-1: Schematic diagram of the CNN. Three-dimensional RGB images 
consisting of segmented, normalized thrombus R2*, QSM and GRE magnitude 
images are fed into a network consisting of 3 convolutions layers with 
average pooling layers in between and a dropout layer at the end, before a 
final fully-connected layer. Padding is employed to retain image size in the 
convolutional layers. 
3.2.5.2 Data augmentation 
Given the relatively small thrombus MR slice dataset available for network 




image data augmentation was employed and implemented to various degrees 
in order to observe its effect on network performance. Augmentation 
consisted of three distinct components: input sampling equalization, image 
transformation, and dataset duplication. 
For input sampling equalization, oversampling of training data was 
performed to equalize the distribution of thrombus RBC content. Thrombus 
MR slices randomly selected to be in the training set were first binned based 
on RBC content in 5% intervals, and underrepresented bins had all slices 
repeatedly sampled until their count equaled the nearest integer multiple of 
the bins original slice count less than or equal to the most represented bin. 
This resampling strategy is similar to the class-aware sampling strategy that 
has previously been employed on categorical data.27 A representative training 
set RBC distribution before and after input sampling equalization is shown in 
Figure 3-2. 
 
Figure 3-2: Representative training set thrombus RBC content distribution 
(A) before and (B) after input sampling equalization. 
For image transformation, a group of geometric transformations were 
randomly applied to both the training and testing datasets. Random 
transformations were performed within predefined ranges: rotations between 




reflections across the X and Y axis, scaling between 0.7 to 1.3 and shearing 
between -30 to 50°. An example 3-channel thrombus input slice before and 
after transformation, with its base images, is shown in Figure 3-3. 
Finally, for dataset duplication the entire training set was copied at up to a 
×5 multiple prior to network training. When employed, it was implemented 
after input sampling equalization and before image transformation, so that 
all slices inputted into the network were unique. 
 
Figure 3-3: An example thrombus (A) R2*, (B) QSM, (C) GRE magnitude 
image slice, shown inside its scanning vial, along with the (D) FIESTA-C 
image used for segmentation. The resulting normalized, segmented thrombus 
RGB image slice used as CNN input is shown (E) before and (F) after random 
image transformation. R2*, QSM and GRE magnitude pixel values represent 
the red, green and blue image color channels, respectively. 
3.2.5.3 Network evaluation 
The network was evaluated using 8-fold cross validation, where the mean 




and root mean square error (RMSE) across all folds were used for network 
assessment. Care was taken to ensure no slices associated with the same 
thrombus were mixed between the training and testing subsets within each 
cross-validation fold. The network was separately trained and evaluated with 
8 different data augmentation strategies: no augmentation, input sampling 
equalization or image transformation only, input sampling equalization and 
image transformation, and input sampling equalization and image 
transformation with dataset duplication of ×2 – ×5 multiples. Across each of 
these network implementations hyperparameters sensitive to the size of the 
input dataset were iteratively tested: training epochs were varied between 4 
to 9 in steps of 1, batch size was varied between 6, 8 and 12, and dropout was 
varied between 0 to 0.4 in steps of 0.1. Results from the best network 
iteration associated with each data augmentation strategy were recorded. 
The training time for a single 8-fold cross validation experiment was as fast 
as 86 seconds for the unaugmented dataset to as long as 32 minutes for the 
×5 duplicated, equalized, transformed dataset on a dual-core CPU (Intel Core 
i5) with 16 Gb of RAM. 
 3.2.6 Statistical analysis 
In addition to accuracy, absolute error and RMSE, network performance was 
also evaluated as the correlation between histological and predicted RBC 
content, using Pearson’s r and slope. Statistical analysis was performed using 
GraphPad Prism (v8.2.1; GraphPad Software, La Jolla, CA). 
 
3.3 Results 
The mean thrombus RBC content determined from histological analysis was 
39 ± 13% (median: 38%; interquartile range: 30 – 49%; min: 12%, max: 61%). 




histological RBC content at each level of data augmentation are shown in 
Table 3-2. 
In general, the networks correctly predicted thrombus RBC content, with an 
accuracy and error that improved as more extensive augmentation was 
performed, as expected. In particular, a large improvement in network 
accuracy was seen after both input sampling equalization and image 
transformation were applied, increasing it from 66% to approximately 72%. 
With both equalization and transformation applied, increased training set 
duplication did not further increase accuracy but minorly improved RMSE 
from 10.3% to approximately 9.8%. For reference, a naive prediction 
(prediction of the overall mean histological RBC percentage for all thrombi) 
would produce an accuracy, absolute error and RMSE of 54.2, 10.5 and 
12.4%, respectively. 
 
Regression curves plotting the median predicted thrombus RBC content 
against that determined through histology were used to determine 
correlation coefficients and linear regression slopes, and are listed for each 
best-performing network iteration in Table 3-2. Here, input equalization and 
image transformation applied individually decreased correlation and 
regression slopes compared to the unmodified dataset, but with both applied 
Table 3-2: Performance of the CNN for thrombus histological RBC content prediction 














F F ×1 66.1 8.26 9.83 0.51 0.25 
T F ×1 66.5 8.22 10.06 0.40 0.22 
F T ×1 67.5 8.06 10.03 0.27 0.08 
T T ×1 73.9 7.99 10.33 0.46 0.24 
T T ×2 72.1 8.07 9.85 0.53 0.29 
T T ×3 71.0 7.85 9.91 0.53 0.33 
T T ×4 72.2 8.01 9.83 0.55 0.32 





training set duplication improved correlation and slope up to 0.57 and 0.34, 
respectively, in the ×5 duplicated dataset. 
Regression plots from the network iterations with the best accuracy, absolute 
error and RMSE (bold in Table 3-2) are shown in Figures 3-4A – C. Despite 
the highest accuracy achieved being the network iteration trained on 
augmented data at only ×1 duplication, its distribution of RBC content 
predictions is noticeably flatter than those trained on larger datasets, 
implying the network learned to make predictions only within a narrow 
range of RBC content. This yields poor prediction accuracy in thrombi with 
very high or low RBC content, resulting in a high RMSE value of 10.33%, the 
largest in Table 3-2. RMSE weighs large individual residuals more heavily 
than absolute error; the discrepancy between this network iteration’s high 
accuracy and poor RMSE underscores the need to consider multiple 
descriptive statistics when evaluating network ability. 
In general, all networks predicted RBC content more accurately in thrombi 
whose histological values were closer to the mean than in those further 
outside it. When the thrombi included in the regression plots are limited to a 
narrower range of RBC content closer to the mean (20 – 45%), slopes of the 
prediction curves increase substantially, reaching up to 0.89 in the network 
trained on the ×5 duplicated dataset (Figures 3-4D – F). Network 
performance results corresponding to this trimmed subset of predictions are 
listed in Table 3-3. In this subset network performance is greatly improved 
compared to that achieved on the entire dataset, suggesting that this network 
may be capable of producing more accurate RBC content predictions when 
trained on larger data sets, but is hindered here by the limited data available 






Figure 3-4: Linear regression plots of the CNN predicted thrombus RBC 
content against the histological value for best-performing network iterations 
on the equalized, transformed dataset with (A) ×1, (B) ×3, and (C) ×5 
duplication, respectively. Plotted are the median predictions from all MR 
slices available for each thrombus. These same predictions replotted with 
only thrombi with histological RBC content between 20 – 45% are shown in 
(D), (E) and (F), respectively. 
 
Table 3-3: Performance of the CNN for thrombus histological RBC content prediction 
when limited to thrombi between 20 – 45% RBC content (T/F: true/false; ×n: training 














F F ×1 77.8 5.51 7.38 0.48 0.44 
T F ×1 77.8 6.82 7.87 0.52 0.59 
F T ×1 59.3 8.42 10.69 0.08 0.03 
T T ×1 92.6 4.07 5.64 0.73 0.76 
T T ×2 88.9 4.48 5.49 0.73 0.8 
T T ×3 88.9 4.31 5.87 0.71 0.84 
T T ×4 92.6 4.77 6.01 0.68 0.76 






In order to evaluate the ability of CNNs to predict AIS thrombus RBC 
content, we trained a 3-layer CNN on segmented thrombus MR images 
acquired ex vivo. Even with a modest dataset of 48 thrombi (188 slices) for 
training, this study demonstrates that a CNN is capable of predicting RBC 
content in AIS thrombi solely from MR images with an average accuracy 
above 70%. This was achieved by using data augmentation strategies 
designed to increase the effective size of the dataset and reduce overfitting. In 
spite of augmentation, predictions of RBC content in thrombi with 
histological values closer to the mean were more accurate than those outside 
of it, suggesting the CNN did not have sufficient training data available to 
learn to accurately predict across the full range of thrombus RBC content. 
Our CNN was trained on ex vivo images of retrieved AIS thrombi. We chose 
to perform this study ex vivo to allow easier patient recruitment while 
minimizing patient burden. Our ex vivo imaging protocol is similar to that of 
previous in vitro blood clot imaging experiments,8,9 and ex vivo thrombus MR 
microscopy studies.28 However, unlike previous ex vivo thrombus imaging 
studies, we noted a significant storage effect on the MR values of retrieved 
thrombi. Stroke thrombi retrieved at night were stored in a refrigerator until 
they could be scanned the next available workday, and these thrombi had 
significantly lower R2* and QSM values than those scanned within the same 
day and kept at room temperature. Cold temperatures increase hemoglobin’s 
oxygen affinity, which may have led to thrombus reoxygenation resulting in 
reduced MR R2* and QSM values.29 An explicit examination into the effect of 
various storage conditions on the MR imaging values of stroke thrombi is 
outside the scope of this report and warrants closer study. 
Due to the abovementioned storage effect limiting our dataset to just 188 




the use of data augmentation techniques for improving CNN performance. 
Data augmentation is a widely used method for increasing the diversity and 
depth of input data to improve deep learning network performance, largely by 
reducing network overfitting of training data.30 Here, we oversampled our 
dataset such that thrombi of all RBC contents were equally represented in 
the training dataset. Input sampling equalization through oversampling is 
one of the most common methods for dealing with class imbalance in deep 
learning, and forces the network to learn features relevant to the entire 
dataset rather than just the most common entries.31 Additionally, we applied 
a multitude of random image transformations to our dataset, which has 
shown to outperform single transformations applied on their own.32,33 We 
used geometric transformations specifically to avoid the network focusing on 
irrelevant characteristics of the thrombi such as orientation and shape, the 
latter of which can be altered during thrombectomy. Finally, we increased the 
size of the training dataset directly by duplicating the entire set prior to 
image transformation, which has proven to improve the performance of CNNs 
trained on small datasets.33 We applied these data augmentation techniques 
sequentially, and it is notable that the largest improvements in network 
performance relative to the original, unaugmented dataset were observed 
only after input equalization and image transformation were applied 
together. This highlights the benefit of having both balanced and varied 
datasets when training a CNN for thrombus RBC content prediction. 
With the use of data augmentation techniques, the CNN was able to learn to 
predict RBC content in thrombi with approximately 72% accuracy and 8% 
mean absolute error. It is difficult to precisely define what level of accuracy 
would be required for a thrombus RBC content predictor to be clinically 
useful. Studies examining the relationship between histological thrombus 
RBC content and successful recanalization following EVT have found an 




the difference between rtPA-resistant thrombi and those untreated was 
approximately 10%.35 A mean absolute error less than the average difference 
between these clinical groups suggests that even a CNN trained on a small 
dataset has the potential to be clinically useful, particularly considering that 
an improvement in the network’s performance would reasonably be expected 
if trained directly for these tasks. 
Despite the respectable overall accuracy, weaknesses were apparent in that 
the predictive ability of the CNN was noticeably poorer for thrombi with RBC 
content outside the mean histological value. We showed regressive plots of 
the most accurate portion of the thrombus predictions to demonstrate the 
CNNs potential capability when given a richer dataset, but the cut-offs to 
where CNN accuracy decreased are instructive. RBC content prediction 
accuracy was poor in thrombi with a less than 20% or greater than 45% RBC 
percentage. Just 4 thrombi had RBC content less than 20%, so it is 
reasonable that the CNN would perform poorly in this subset due to a lack of 
representative data, even after input sampling equalization. In contrast 
however, 17 of the 48 thrombi had an RBC content greater than 45%. This 
bound could instead be reflective of the fact that blood clots with 40-60% RBC 
content have similar R2* rates due to their similarly heterogeneous 
composition; this may have reduced their distinguishability within the CNN.8 
While it is expected that the CNN performance would improve with 
additional thrombi available for study, this suggests that predicting RBC 
content of thrombi in the range of 40-60% in particular may be more 
challenging. Studies have not demonstrated a benefit, however, for finely 
differentiating between RBC-rich thrombi; current research suggests that all 
thrombi in this RBC content range would likely yield successful 
recanalization when treated with EVT, for example.3,34 
This study has a number of limitations. We made the assumption that all 2D 




value derived from histology. While there is evidence suggesting that 
composition varies little throughout thrombi,26 slight variations in RBC 
content across each MR slice would limit the CNN accuracy. We used an 8-
fold cross validation to evaluate our network instead of defining a distinct 
testing set. Doing so means the generalizability of the network maybe be 
overestimated, but cross-validation has been recommended for datasets that 
are too small to include a test set of meaningful size.36 Finally, we performed 
our imaging ex vivo after thrombi had been retrieved through EVT. This 
allowed us to perform our imaging study without impacting the course of 
patient treatment, but introduces potential confounding factors which could 
affect imaging results such as the effect of thrombus storage outside the body, 
potential alterations in the thrombus structure during the EVT procedure, 
and differences in temperature and field inhomogeneity relative to in vivo 
imaging. Chosen scan parameters and acquisition hardware were selected to 
be directly translatable to in vivo head imaging, and hence were not 
optimized for ex vivo samples. Performing the study ex vivo also meant that 
the samples were limited to stroke thrombi that were retrievable by EVT and 
that did not resolve following rtPA administration. While evaluation of this 
technique in vivo with a larger sample size is ultimately required to 
demonstrate utility in AIS patients, the results presented here suggest CNNs 
are capable of predicting stroke thrombus RBC content using MR images. 
 
3.5 Conclusion 
In this study, we demonstrated that a 3-layer CNN is capable of RBC content 
prediction in AIS thrombi using ex vivo R2*, QSM and late-echo GRE 
magnitude MR images. We improved CNN performance by employing data 
augmentation involving equalized input sampling, geometric transformation 




content with an overall accuracy of approximately 72% and an absolute error 
of approximately 8%. The rapid imaging protocol and straightforward 
network design used in this study enables ready translation towards in vivo 
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3.7 Supplementary material 
 
Supplementary Figure 3-1: Bland-Altman plot showing the difference 
between thrombus histological RBC content and that predicted through mean 
R2* and QSM values using the methods described in Chapter 2. Predicted 
RBC content consistently underestimated the histological values, yielding a 
mean error of 20 ± 22% and a mean absolute error of 25 ± 16%. 
 
Supplementary Figure 3-2: Effect of storage method and time between 
thrombus retrieval and MR imaging on mean thrombus (A) R2* and (B) QSM 
values. Thrombi were either stored at room temperature and scanned within 
the same workday, or stored in a fridge until the next available workday. 
Two-tailed T-tests between the two groups R2* and QSM values yielded 





Supplementary Figure 3-3: Thrombus multi-section histological results. 
Mean RBC content is shown at 3 or 4 evenly spaced intervals through the 
retrieved stroke thrombi. Red dots indicate the average RBC content values 














Ex vivo thrombus MR imaging features and 
patient clinical data enable prediction of acute 
ischemic stroke etiology 
 
4.1 Introduction 
Determination of acute ischemic stroke etiology is a critical component of 
reducing stroke recurrence risk, but in current clinical practice etiology 
remains undetermined in approximately one third of cases.1 Histological 
analysis of retrieved thrombi has demonstrated that thrombus composition, 
particularly red blood cell (RBC) content, can be used to differentiate between 
etiologies, but histological analysis is impractical as a rapid diagnostic tool.2-4 
Medical imaging offers the potential to non-invasively infer information, 
including but not limited to thrombus composition, supporting the prompt 
determination of stroke etiology. 
Magnetic resonance (MR) imaging and computed tomography (CT) have each 
demonstrated sensitivity to thrombus RBC content, through the qualitative 
susceptibility vessel and hyperdense artery signs, respectively.5-7 However, a 
recent meta-analysis found no significant association between these signs 
and stroke etiology, and an analysis of the THRACE randomized controlled 
trial found the diagnostic accuracy of the susceptibility vessel sign for 
etiology determination to be just 49%.8,9 Quantitative MR and CT techniques, 
in particular those measuring R2* and quantitative susceptibility mapping 




quantitatively assess the RBC content of prepared blood clots in vitro,10-13 but 
these values too have failed to produce significant associations with stroke 
etiology in vivo.14,15 Past imaging approaches for stroke thrombus 
characterization may be limited by their use of a single imaging value or 
metric to represent entire thrombi, which is discordant with histological 
studies demonstrating that the structure of stroke thrombi is complex and 
heterogeneous.16 
Radiomics is the conversion of medical images to mineable high-dimensional 
data, from which quantitative imaging features can be derived.17 Such 
imaging features may be used as input into machine learning algorithms, 
enabling analysis of information within contexts beyond that perceptible to 
the human eye. Imaging features related to object texture, in particular, have 
demonstrated aptitude for characterization of tissues with heterogeneous 
structure, such as tumours.18-21 In the field of stroke imaging, texture 
features have been used to predict post-stroke impairment and in lesion 
detection.22,23 They have also been applied towards the characterization of 
thrombi, showing sensitivity to RBC content in vitro on R2* maps as well as 
for predicting response to intravenous recombinant tissue plasminogen 
activator (rtPA) and endovascular therapies (EVT) in stroke thrombi in vivo 
on non-contrast CT.24-26 However, texture features have not been previously 
applied in stroke thrombi towards the determination of etiology. 
In this study, we evaluate the ability of radiomics features applied to 
quantitative MR images of retrieved ischemic stroke thrombi, in combination 
with patient clinical data, for the prediction of stroke etiology using machine 
learning. Specifically, we extract image size, shape and texture features from 
ex vivo thrombus R2*, QSM and fat fraction (FF) maps, and mine clinical 
characteristics of the stroke patients, to train random forest classifiers which 
discriminate between cardioembolic (CE) and large artery atherosclerotic 




In contrast to the deep learning methods described in Chapter 3, machine 
learning was used in this study because it more readily allows the derivation 
of models that incorporate thrombus MR imaging and patient clinical data 
together. 
 
4.2 Materials and methods 
4.2.1 Study design and inclusion criteria  
Institutional research ethics board approval was obtained for this study. 
Acute ischemic stroke patients treated with EVT at London Health Sciences 
Centre University Campus were consecutively enrolled between the periods 
of February 2016 to November 2017 and October 2019 to March 2020. Data 
from the earlier (training) cohort were used to select relevant imaging and 
clinical features and train the machine learning models, while data from the 
later (validation) cohort were used to evaluate their performance against an 
independent dataset. Patients or their substitute decision makers were made 
aware of the study at the time consent was given for EVT, and gave informed 
consent after the procedure was completed and a thrombus was retrieved. 
EVT was performed using a stentriever or Penumbra System® at the 
interventionalist’s discretion. Inclusion criteria for the study were age greater 
than 18 years old, CE or LAA stroke etiology, no recent prior stroke and 
sufficient thrombus material retrieved for study (>2 mm in all dimensions). 
Thrombi were saved upon retrieval for subsequent MR imaging. 
Patient clinical data was collected and used as additional input in the 
machine learning models. Clinical history parameters obtained for the study 
included: age, gender, prior stroke history, hypertension, diabetes, 
hyperlipidemia, coronary artery disease, cardiac valve disease, peripheral 




disease, obesity, prior infections, active cancer, antiplatelet usage, 
anticoagulant usage, and stroke etiology as determined by the Trial of ORG 
10172 in Acute Stroke Treatment (TOAST) criteria.27 Procedural parameters 
included: rtPA administration, intracerebral hemorrhage, stroke recurrence, 
final TICI score, arrival NIHSS, occlusion side, occlusion location, number of 
EVT passes, and EVT duration. Blood work parameters included: 
triglycerides, cholesterol, high-density lipoprotein, low-density lipoprotein, 
glucose, leukocytes, and troponin. 
With the exception of stroke etiology, all clinical parameters included in this 
study are obtainable within a few days of acute stroke; this was to ensure 
that derived models are applicable within the acute to subacute stage of 
stroke treatment. A summary of basic clinical data for both the training and 
validation cohorts is given in Table 4-1. 
4.2.2 Thrombus storage and imaging 
Thrombi retrieved in the training cohort were stored inside a 150 mL plastic 
jar containing a gauze pad (TELFA™) wetted with heparinized saline to 
retain moisture. Those retrieved during the daytime were kept at room 
temperature and scanned within 6 hours of retrieval; otherwise thrombi were 
kept in a refrigerator until the following workday. All thrombi retrieved in 
the validation cohort were kept at room temperature and scanned within 6 





Thrombi were scanned inside 1 cm diameter polystyrene vials containing 
porcine plasma, inserted vertically into an agar-filled container. A small agar 
plug was placed at the bottom of the vials so that the thrombi sat flat on their 
surface. When more than one thrombus specimen was obtained from a 
patient, each piece was scanned in a separate vial and analyzed individually. 
Scanning was performed at 3.0 T using a whole-body MRI scanner (GE 750, 
GE Medical Systems, Milwaukee, WI) with a 32-channel receive head coil. 
Scans were acquired using a 3D multi-echo bipolar GRE sequence designed 
for clinical imaging in vivo;28 the sequence includes two 5-echo trains: the 
Table 4-1: Summary of clinical details for each patient cohort 
Patient cohort Training (n = 49) Validation (n = 9) 
Age (mean ± SD) 72 ± 15 74 ± 17 
Sex, female 20 (41%) 4 (44%) 
Etiology 
   Large artery atherosclerosis 
   Cardioembolism 
Number of thrombi 
   Large artery atherosclerosis 

















   ICA 
   ICA + MCA M1 
   MCA M1 
   MCA M1 + M2 
   MCA M2 
   Vertebrobasilar 
EVT technique 
   Stent 





















Prior stroke 10 (20%) 2 (22%) 
Hypertension 34 (69%) 7 (78%) 
Diabetes 6 (12%) 3 (33%) 
Obesity 





Hyperlipidemia 23 (47%) 7 (78%) 
Coronary artery disease 10 (20%) 4 (44%) 
Cardiac valve disease 4 (8%) 1 (11%) 
Chronic kidney disease 0 (0%) 2 (2%) 
Abbreviations: IV tPA, intravenous recombinant tissue plasminogen 




first train was optimized for chemical shift imaging (first echo time (TE) = 
3.20 ms, echo spacing = 1.46 ms); the second train was optimized to highlight 
susceptibility-related contrast (first TE = 16.75 ms, echo spacing = 7.15 ms). 
The remaining scan parameters were repetition time = 47.6 ms, bandwidth = 
142.86 kHz, flip angle = 10°; field of view = 18 cm; matrix size = 192 × 192 × 
36, for a final voxel size of 0.94 × 0.94 × 1.0 mm3. Total acquisition time was 5 
minutes 33 seconds. A FIESTA-C sequence with identical resolution and 
bandwidth was also acquired to facilitate thrombus segmentation (TE = 3 ms, 
TR: 6.1 ms, flip angle: 40°, phase cycles = 4, scan time = 2 min 47 sec). All 
scans were acquired in the coronal plane, with the phantom lying flat along 
the MR table and vials aligned perpendicular to B0. Thrombi sat horizontal 
relative to the long axis of the vials, and were also aligned perpendicular to 
B0. 
4.2.3 Image post processing 
Raw image data were reconstructed in Matlab (Matlab 8 R2015a; 
Mathworks, Natick, MA) using the Orchestra Software Development Kit (GE 
Healthcare; Milwaukee, WI). Complex channel combination was performed 
using singular value decomposition and phase errors resulting from the 
bipolar acquisition were removed.29 R2*, FF and QSM maps were generated 
using the B0-NICE and MEDI QSM algorithms.29,30 Thrombi were segmented 
semi-automatically on the FIESTA-C images, which are naturally co-
registered with the quantitative maps. 
4.2.4 Radiomics analysis and machine learning models 
A radiomics and machine learning Matlab method previously developed by 
Vallières et al. was adapted for use in this study.20 The code includes a 
feature selection portion and a random forest model derivation portion using 




one each using thrombus imaging and patient clinical data only, and one 
derived from the combined set of imaging and clinical features. For the 
imaging model, multivariate logistic regression (MLR) as provided in the code 
was used to select features, while for the clinical model statistical analysis 
was performed to select features individually based on statistical significance. 
4.2.4.1 Feature extraction and selection 
To select imaging features, a total of 4 shape (size, volume, solidity, 
eccentricity) and 43 texture features (supplementary Table 4-1) were 
extracted from each segmented thrombus’ R2*, QSM and FF maps. Feature 
extraction was performed under the possible 8 combinations of the following 
extraction parameters: 8, 16, 32 or 64 total gray levels, with uniform or 
equal-probability quantization. Images of a representative thrombus before 
and after quantization are shown in Figure 4-1. Imaging features were 
selected using imbalanced-adjusted MLR, where models were derived of 1 to 
10 variables (model order) by maximizing the receiver-operating 
characteristic (ROC) curve using the 0.632+ bootstrap method (AUC632+)31 to 
differentiate between CE and LAA stroke.20 Features included in the model 
with highest AUC632+ of the lowest model order were selected to build the 
imaging random forest model. 
For clinical variables, individual clinical parameters found to differ between 
CE and LAA patients within the training cohort to a level of P < .1 were 
selected as the features for the clinical random forest model. The combined 





Figure 4-1: Representative segmented thrombus R2* (top), QSM (middle) and 
FF (bottom) images shown in (A) original form, (B) after equal-probability 
quantization with 64 bins and (C) after uniform quantization with 8 bins. 
These extraction parameters control the pixel distribution and coarseness 
under which features are extracted, respectively. 
4.2.4.2 Random forest analysis 
The random forest classifier was used as it is capable of incorporating 
numerical and categorical data and has been shown to create highly 
generalizable models.32 Random forest classifiers were built using 500 trees 
trained on bootstrapped samples from the training cohort, and were tested on 
the “out-of-bag” measurements from the training cohort and using all trees on 
the validation cohort. Overall AUC, sensitivity, specificity and accuracy of the 
predicted, compared to clinically determined, stroke etiology were recorded 




 4.2.5 Statistical analysis 
Clinical data are displayed as mean ± standard deviation and count 
(percentage) for numerical and categorical variables, respectively. One-way 
analysis of variance and chi-squared tests were used to assess differences in 
numerical and categorical clinical variables, respectively, between CE and 
LAA strokes in the training cohort. Statistical analysis was performed using 




In this study 128 thrombi were collected from 78 patients, however after 
excluding patients based on refused consent (n=1), recent prior stroke (n=3) 
or non-CE or LAA etiology (embolic stroke of undetermined source: n=12; 
dissection:  n=2; unknown: n=2), a total of 91 thrombi from 58 patients were 
available. 76 thrombi from 49 patients were included in the training cohort 
while 15 thrombi from 9 patients were included in the validation cohort. 
Differences in clinical characteristics between CE and LAA stroke within the 
training cohort are shown in Table 4-2. Patients with CE stroke were 
significantly older, and had significantly lower incidence of smoking, 
triglyceride levels and trended towards lower incidence of hemorrhagic 
transformation; these four variables were selected as features for the clinical 
random forest model. 
Multivariate logistic regression performed on the image features extracted 
from thrombus R2*, QSM and FF maps in the training cohort yielded an 
optimal model order of 4. The identified features selected for the imaging 
random forest model and are listed in Table 4-3. Notably, only features from 




associated with higher skewness in overall QSM values, lower variance in 
overall FF values, higher variance in QSM gray-level run lengths, and more 
outliers in QSM size zone matrices. Hence, CE stroke was associated with 
lower variability in thrombus FF values and higher variability and 
inconsistency in QSM values. 
The performance of the imaging, clinical and combined models for stroke 
etiology prediction in both cohorts is listed in Table 4-4; respective ROC 
curves are shown in Figure 4-2. AUC values of each model were always 
higher when forming predictions on the training cohort than the validation 
cohort, as expected. Within each cohort, the combined model produced the 
highest AUC value, followed by the clinical and then image-texture model. 
The combined classifier achieved an AUC and accuracy of 0.893 and 93%, 






Table 4-2: Clinical details of CE and LAA strokes within the training cohort 
Characteristic CE (n = 41) LAA (n = 8) P value 
Age (years) 74 ± 15 61 ± 10 0.028 






































1.7 ± 1.4 
54 ± 35 
1.3 ± 0.7 
3.6 ± 0.8 
1.0 ± 0.4 
1.9 ± 0.7 
5.7 ± 0.7 
8.8 ± 2.6 







































1.7 ± 1.9 
95 ± 41 
3.6 ± 3.2 
5.1 ± 1.3 
0.9 ± 0.3 
2.8 ± 1.0 
7.2 ± 2.2 
9.2 ± 2.1 
14 ± 12 
0.320 
Prior stroke 0.725 




Coronary artery disease 0.117 
Cardiac valve disease 0.357 
Peripheral artery disease 0.430 
Smoking, past 5 years 
Past DVT 
Chronic kidney disease 
Obesity 
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Arrival NIHSS (median (IQR)) 
Occlusion side: 
   Right 
   Left 
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Occlusion site: 
   ICA 
   ICA + MCA M1 
   MCA M1 
   MCA M1 + M2 
   MCA M2 
   Vertebrobasilar 
EVT passes 














































Abbreviations: TIA, transient ischemic attack; DVT, deep vein thrombosis; TICI, 
thrombolysis in cerebral infarction; NIHSS, National Institutes of Health stroke scale; 
MCA, middle cerebral artery; ICA, internal carotid artery; IV rtPA, intravenous 
recombinant tissue plasminogen activator; EVT, endovascular therapy; HDL, high-







Figure 4-2: ROC curves for the determination of CE vs. LAA stroke etiology 
within the training (A) and validation (B) cohorts using the imaging, clinical 
and combined random forest classifier models. 
 
 
Table 4-3: Thrombus MR imaging texture features selected by MLR for 






Texture type Texture name 











QSM Equal-probability 8 GLSZM GLN 
Abbreviations: MLR, multi-variate logistic regression; QSM, quantitative 
susceptibility mapping; FF, fat fraction; GLRLM, gray-level run-length 
matrix; RLV, run-length variance; GLSZM, gray-level size zone matrix; GLN, 
gray-level non-uniformity.  
Table 4-4: Performance of random forest classifiers for stroke etiology prediction 
Patient cohort Features used AUC Sensitivity (%) Specificity (%) Accuracy (%) 
Training Imaging 0.79 66.7 78.7 76.3 
 Clinical 0.85 62.5 90.2 83.7 

















This study demonstrates the capability of both thrombus MR imaging and 
patient clinical data features for the prediction of ischemic stroke etiology. 
Our imaging texture features were derived from thrombi scanned ex vivo, 
obviating the need to perform in vivo imaging on vulnerable stroke patients, 
while all clinical data included in this study can be accessed through a review 
of patient clinical history, outcome of stroke therapy, and a blood test. 
Features from each of these data types alone were sufficient to predict stroke 
etiology with reasonable accuracy, but when combined yielded a model which 
predicted stroke etiology in an independent test set with a high degree of 
accuracy. 
Thrombus imaging texture models have previously been developed to form 
predictions related to stroke. Thrombus CT texture features were used in two 
studies to predict early recanalization following rtPA and EVT therapies, 
respectively;25,26 neither study involved patient clinical data in their analysis. 
Recently, a study by Chung et al. used features extracted from transverse 
line profiles of thrombus GRE blooming artifact to predict stroke etiology.33 
This study tested multiple machine learning classifiers and also did not 
incorporate clinical data. Their highest AUC of 0.93 was reached using 
random forest and logistic regression models, but achieved accuracies of only 
75 and 77%, respectively. Thrombus GRE blooming artifact appearance has 
been shown to vary between scanners,34 suggesting that measurements 
obtained from these qualitative images may not be widely generalizable. In 
contrast, the current study uses features extracted from quantitative MR 
maps, and incorporates information beyond susceptibility-based information 
(fat fraction). Multiple studies have examined associations between patient 
clinical variables and stroke etiology, and older age and lower incidence of 




studies did not assess triglyceride levels or intracerebral hemorrhage 
occurrence, but separate studies examining hemorrhagic transformation 
incidence following ischemic stroke treatment have identified lipid levels and 
etiology as associated risk factors.39,40 
In this study we created random classifier models using four imaging, four 
clinical and eight combined total features. Both the imaging and clinical-only 
models were able to form accurate predictions of stroke etiology, however the 
imaging-only model was outperformed by the clinical-only model in both the 
training and validation cohorts. This suggests that the thrombus texture 
features may not be as predictive or generalizable as clinical features when 
considered independently. Conflicting results have been reported on the 
associations between thrombus composition and etiology,3,5,6 which would 
affect imaging features, while CT texture features have been questioned for 
their inter-scanner variability and sensitivity to acquisition parameters.41 
Nonetheless, the combined model outperformed both isolated models in the 
training and validation cohorts, suggesting that the imaging and clinical 
features provided independent and complimentary information for forming 
etiology predictions. 
Of the thrombus features selected in the imaging model, only features from 
QSM and FF maps were selected, while R2* went unused. Similar to QSM, R2* 
is sensitive to hemoglobin-induced susceptibility effects but holds a quadratic 
relationship with RBC content, unlike QSM which is linear.10,42 It is possible 
that information derived from thrombus R2* pixel distributions is less 
informative of RBC content than those from QSM, due to similarity in R2* 
values of thrombi in the region between 40-60% RBC content.10 The higher 
variance and presence of outliers within QSM values of CE thrombi suggests 
that their RBCs may be more deoxygenated than those of LAA thrombi. In 
contrast to R2* and QSM, FF provides a unique assessment of thrombus lipid 




higher triglyceride levels in LAA patients suggests that LAA thrombi may be 
composed of higher, more variable amounts of lipid due to high triglyceride 
levels in the blood. The few studies that have identified lipid content within 
histologically analyzed stroke thrombi have done so exclusively with LAA 
thrombi.43-45 
For this study, we used ex vivo imaging features derived from retrieved 
stroke thrombi, and clinical features available as part of standard stroke 
patient assessment. We have therefore demonstrated our models’ utility only 
for ex vivo thrombus examination, but with this method it is easier to recruit 
patients and avoids the challenges associated with scanning acute stroke 
patients prior to treatment. All clinical features utilized in this paper are 
readily accessible through a review of patients’ clinical history, outcome of 
stroke treatment, and the results of blood tests. Taken together, all 
components of the developed models are relatively easily accessible to 
clinicians, do not require in vivo stroke patient scans, and provide accurate 
predictions of etiology which may enable differentiation of CE and LAA 
stroke much sooner than with long term electrocardiographic monitoring. 
This study has a number of limitations. Our sample size was small, 
particularly for the validation cohort. Recruitment for this cohort was cut 
short due to the COVID-19 pandemic, and sample size was further limited by 
including only patients with known CE or LAA etiologies. Thrombus imaging 
was conducted ex vivo, meaning we cannot assess the capability of this 
method for in vivo scans. Chosen scan parameters and acquisition hardware 
were selected to be directly translatable to in vivo head imaging, and hence 
were not optimized for ex vivo samples. It is possible the retrieved stroke 
thrombi could have different imaging feature values if scanned in vivo, due to 
the forces exerted on the thrombus by vessel occlusion which may influence 
texture features, physical alterations to the thrombus during and following 




from performing scans ex vivo. The fact that only successfully retrieved 
thrombi were included in the study introduces bias through excluding 
thrombi which could not be retrieved by EVT or which resolved following 
rtPA administration. Multiple thrombi retrieved from patients were analyzed 
separately and treated as independent, though correlation between their 
imaging values is likely. Assessment of thrombus histological RBC content 
may have improved model performance but was not included. A prospectively 
recruited cohort of patients is required to evaluate the clinical utility of the 
stroke etiology predictions made by the machine learning models. 
 
4.5 Conclusion 
In this study, we demonstrated that features derived from ex vivo thrombus 
MR imaging and patient clinical data can be used independently or in 
combination to differentiate between CE and LAA ischemic stroke. Our 
combined machine learning model generated highly accurate predictions of 
stroke etiology, and outperformed the models derived from imaging and 
clinical data alone. The rapid ex vivo imaging protocol and readily available 
clinical features used in this study makes this method widely applicable for 
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4.7 Supplementary material 
 
Supplementary Table 4-1: Texture features used in this study; more detail 
available in Vallières et al. 2015 
















Gray-level run-length matrix 
(GLRLM) 
Short Run Emphasis (SRE) 
Long Run Emphasis (LRE) 
Gray-Level Non-uniformity (GLN) 
Run-Length Non-uniformity (RLN) 
Run Percentage (RP) 
Low Gray-Level Run Emphasis (LGRE) 
High Gray-Level Run Emphasis (HGRE) 
Short Run Low Gray-Level Emphasis (SRLGE) 
Short Run High Gray-Level Emphasis (SRHGE) 
Long Run Low Gray-Level Emphasis (LRLGE) 
Long Run High Gray-Level Emphasis (LRHGE) 
Gray-Level Variance (GLV) 
Run-Length Variance (RLV) 
Gray-level size zone matrix 
(GLSZM) 
Small Zone Emphasis (SZE) 
Large Zone Emphasis (LZE) 
Gray-Level Non-uniformity (GLN) 
Zone-Size Non-uniformity (ZSN) 
Zone Percentage (ZP) 
Low Gray-Level Zone Emphasis (LGZE) 
High Gray-Level Zone Emphasis (HGZE) 
Small Zone Low Gray-Level Emphasis (SZLGE) 
Small Zone High Gray-Level Emphasis 
(SZHGE) 
Large Zone Low Gray-Level Emphasis (LZLGE) 
Large Zone High Gray-Level Emphasis 
(LZHGE) 
Gray-Level Variance (GLV) 
Zone-Size Variance (ZSV) 
Neighbourhood gray-tone 











Conclusions and Future Directions 
 
5.1 Conclusions 
Stroke thrombus MR imaging has been previously examined as means to 
provide additional information to improve the treatment of acute ischemic 
stroke. However, past methods tested in vivo have utilized unreliable 
qualitative metrics, while more advanced, quantitative techniques have thus 
far been limited almost exclusively to in vitro or preclinical experiments. The 
work of this thesis serves to expand the capability of MR in stroke thrombus 
imaging, specifically by exploiting quantitative information and advanced 
artificial intelligence techniques applied to thrombus ex vivo images for the 
prediction of ischemic stroke etiology. 
In Chapter 2, I demonstrate that blood clot R2* and QSM values are each 
sensitive to RBC content and oxygenation. This accords with the findings of 
previous in vitro clot studies, however this work was the first to examine 
these MR parameters on clots of simultaneously varied composition and 
oxygenation. I show that clot R2* and QSM values vary drastically as their 
oxygenation evolves throughout ageing, and importantly that these changes 
dominate the inherent differences found between clots of different RBC 
content. Because of this, the examination of either R2* or QSM alone will not 
be sufficient to determine RBC content in acute stroke thrombi, where 
oxygenation is never known. I devised a metric using the ratio of clot R2* to 
QSM values and showed that it allowed prediction of RBC content 




may enable accurate RBC content determination in stroke thrombi. 
Additionally, I demonstrated that FF and QSM mapping are capable of 
detecting lipidic and calcified components within blood clots, respectively, 
regardless of composition or oxygenation; the identification of these 
uncommon components within stroke thrombi would be directly informative 
of etiology. Overall, this work established the potential of our 
multiparametric, quantitative MR imaging method for the characterization of 
ischemic stroke thrombi. 
In Chapter 3, I applied a deep learning CNN to ex vivo stroke thrombus R2*, 
QSM and GRE images to predict histological RBC content. To my knowledge, 
this is the first study to use deep learning to analyze MR images of stroke 
thrombi. I demonstrate that CNNs are capable of leveraging the information 
available within our multiparametric MR dataset to form accurate 
predictions of thrombus RBC content, specifically with a mean absolute error 
of approximately 8%. The small number of thrombi available for this study 
and the improvements in network accuracy observed when applying data 
augmentation suggest that greater network performance is achievable if 
trained on a larger dataset. 
Finally, in Chapter 4, I present a machine learning approach employing 
radiomics texture features extracted from thrombus R2*, QSM and FF maps 
along with clinical patient data to predict stroke etiology. Similar methods 
have been employed on thrombus CT images to predict response to rtPA and 
endovascular therapies,1,2 however to my knowledge this was the first 
application of machine learning on thrombus texture features for stroke 
etiology prediction. The models achieved accurate etiology prediction with 
AUC and accuracy values of 0.68 and 67%, respectively, using thrombus 
texture information alone, 0.8 and 89% using clinical information alone, and 
0.89 and 93% when using both sets of features. Relative to previous work 




achieved accuracies of 49%,3 and clinical models which have achieved AUC 
values of 0.85,4 the combined model outperformed past attempts and has 
yielded a novel, promising method to improve clinical etiology determination 
in acute ischemic stroke. 
 
5.2 Limitations 
5.2.1 Analysis of blood clot RBC, lipid and calcium content  
The limitations of the study presented in Chapter 2 stem largely from its in 
vitro design; each component included in clot construction was mimicking a 
pathological human process. In particular, clots were prepared from porcine 
blood and thus may possess innately different relaxation and susceptibility 
values than that of human thrombi. Additionally, the mechanisms underlying 
human thrombus formation are various and complex, and yield thrombi of 
heterogeneous structure.5,6 The clots prepared for this study were 
comparatively simplistically derived, large and homogeneous in structure.  
Another key facet of this study was allowing the initially fully oxygenated 
arterial clots’ oxygenation to change naturally through in vitro ageing, which 
was meant to traverse the breadth of possible oxygenation values observable 
in human thrombi. While measurement of stroke thrombus oxygenation in 
vivo has not been previously investigated, it is likely to be affected by the 
environment in which thrombosis occurs, the age of the thrombus prior to 
embolization, and the duration and severity of the stroke at the time of 
imaging. It is unlikely that all plausible stroke thrombus oxygenation states 
were represented through our static in vitro clot ageing procedure. 
Finally, I used lab materials to represent the lipid and calcified components 




materials do not exactly mimic the components found in stroke thrombi, nor 
is their inclusion as a single large piece of material representative of the all 
possible component distributions, which may also be diffuse or punctate. 
5.2.2 Prediction of stroke thrombus RBC content 
The principle limitation of the 3rd Chapter study is that the thrombi were 
scanned ex vivo, following endovascular retrieval, rather than in stroke 
patients in vivo. While our MR sequence was designed for in vivo imaging 
and may be translated without alteration of any sequence parameters, 
differences in field inhomogeneity, shimming and temperature could all affect 
observed thrombus MR parameters. Scanning in vivo presents additional 
challenges to scan acquisition including flow artifact and patient movement. 
Our study is biased by the ability to only include thrombi retrievable by 
endovascular therapy, and which did not resolve following rtPA 
administration if given. As part of the retrieval thrombus breakage or 
alterations to its size and shape may have occurred which could influence 
observed MR parameters. Additionally, alterations to thrombus oxygenation 
or structure can occur during storage, the time between thrombus retrieval 
and ex vivo scanning. Thrombus segmentation was also not fully automatic 
and additional bias could have been introduced in this step. 
The study was further limited by its small sample size. The inclusion of just 
under 50 thrombi meant that I did not have enough samples to apportion a 
meaningful test set, and instead used cross-validation to evaluate the 
network; this may result in overestimation of the generalizability of the 
model.7 Small sample size is a common limitation for deep learning studies in 
general, which are notorious for using massive datasets to derive 




augmentation to increase effective dataset size suggest that a larger sample 
cohort would be highly beneficial to the performance of the network. 
Our study relied on histological analysis to derive ground-truth values of 
thrombus RBC content. These were derived from a single histology slice and I 
made the assumption that the measured RBC content was representative of 
each thrombus overall, and that the RBC content within every MR slice of 
each thrombus was identical to the histological value. 
5.2.3 Prediction of stroke etiology 
With the exception of an independent test dataset and the use of histology, all 
limitations of the study detailed in Chapter 3 also apply to the study 
described in Chapter 4. This was also an ex vivo imaging study, but here 
radiomics texture features and clinical data were used to form predictions of 
stroke etiology using machine learning. Radiomics texture features can be 
influenced by a number of factors including acquisition parameters and the 
scanner used;8 features extracted from ex vivo thrombus images may vary 
from those acquired in vivo. As with any machine learning study, model 
performance is influenced by the particular texture and clinical features 
chosen a priori for study. Sample size is also a limitation (n = 91 thrombi), 
though more samples were able to be included in this study than that of 
Chapter 3 because histological analysis was not required. 
 
5.3 Future directions 
This thesis presents a quantitative, multiparametric MR technique for 
thrombus analysis to aid in the treatment and management of acute ischemic 
stroke. It is motivated by in vitro work demonstrating capability of our 




demonstrating utility in human stroke thrombi. Besides translation of the 
technique to in vivo studies to directly assess clinical utility, there are a 
multitude of additional applications where our quantitative thrombus 
imaging technique may prove useful, as well as areas where the technique 
may be improved. These are detailed in the following sections ordered by the 
types of experiments to be performed. 
5.3.1 In vitro  
Histological studies have reported that CE thrombi have lower RBC content 
than LAA thrombi,9,10 yet MR imaging studies have consistently found a 
higher presence of susceptibility signs in CE compared to LAA stroke.3,11,12 
This suggests that, in spite of lower overall RBC content, RBCs in CE 
thrombi tend to be drastically more deoxygenated than those found in LAA 
thrombi. Measurement of RBC oxygenation state could therefore provide an 
additional means to predict stroke etiology which complements assessment of 
RBC proportion. 
Measurement of the T1 relaxation rate in RBCs can indicate methemoglobin 
content, one of the two forms of deoxygenated hemoglobin found within 
thrombi.13 Because R2* and QSM are sensitive to deoxygenated hemoglobin 
but insensitive to form (deoxy- or methemoglobin), the addition of the T1 
parameter to the multiparametric analysis may allow explicit determination 
of the proportions of oxy-, deoxy- and methemoglobin content in thrombi. An 
in vitro blood study which related the MR parameters of oxygenated 
(arterial), deoxygenated (venous) and methemoglobin-rich (aged) blood to an 
independent oximetry technique such as blood gas analysis could allow 
mapping of MR parameters to the amount of each hemoglobin form in blood 
clots. Applied to stroke thrombi, such analyses may be indicative of thrombus 




measurement would require an additional sequence to be added to the 
protocol however, necessitating increased scan time. 
5.3.2 Ex vivo 
A number of additional parameters related to stroke treatment remain to be 
studied for associations with thrombus MR imaging. Our technique is 
sensitive to thrombus RBC content, which has been directly related to 
response to endovascular therapy (procedure time, number of passes, 
recanalization score).9,14,15 Machine learning applied to CT thrombus texture 
features, as well as mean thrombus R2* values have each been previously 
used to predict response to endovascular therapy,2,16 however 
multiparametric MRI and more advanced data analysis techniques such as 
deep learning have not been used for this application and may yield superior 
predictions. Though likely correlated to therapy response, associations 
between thrombus properties and long term stroke outcome is an 
understudied area of research where MR machine learning or deep learning 
analysis could also be informative. 
5.3.3 In vivo 
Despite demonstrating potential, our study of etiology prediction from 
thrombus MR features needs to be replicated prospectively in vivo to 
accurately assess its capability to aid in acute ischemic stroke care. MR 
images from a pilot study showing time of flight (TOF) angiography and R2*, 
QSM and FF maps of an ischemic stroke patient with intracranial thrombus 
in vivo are shown in Figure 5-1. In vivo imaging studies additionally enable 
the study of thrombi which could not be retrieved for ex vivo study, allowing 
associations with complications including secondary embolism or 
intracerebral hemorrhage, or failed retrieval by endovascular therapy or 




machine learning studies of thrombus CT texture features,1,2 but to my 
knowledge has never been investigated with quantitative MR imaging. 
 
Figure 5-1: Axial time of flight (TOF) angiography, R2*, QSM and FF maps of 
an ischemic stroke patient with intracranial thrombus (arrow) of 
atherothrombotic origin. High R2* and QSM indicate a deoxygenated, RBC-
rich thrombus, while a high FF suggests the presence of lipid (from plaque 
core). 
For any in vivo analysis technique to be useful in the acute stroke setting, 
rapid derivation of results is required. To this end, the use of semi-automated 
segmentation is the biggest limitation of the work described in this thesis; 
automated in vivo thrombus segmentation is a necessary step for the 
development of a clinically practical thrombus MR analysis tool. Secondary 
processing steps including the image post-processing required to derive our 
quantitative MR parameters could be hastened by translating our Matlab 
code to more efficient programming languages and using more powerful 
processors for computation. While both machine and deep learning models 
are computationally expensive to derive, once trained they are extremely 
efficient for analyzing new data. 
Even if a rapid, fully automated thrombus analysis tool existed, ischemic 




not typically triaged using MRI. While the utilization of MR imaging in acute 
ischemic stroke care is expected to increase following recent changes to 
clinical guidelines,17 its use is still rare due to its relatively long scan times 
compared to CT and so additional clinical applications lacking rigid time 
restrictions should be considered. Thrombus age in deep vein thrombosis 
influences the success rate of fibrinolysis, but remains challenging to 
determine;18 the use of imaging to predict deep vein thrombosis thrombus age 
is an active area of study that has currently seen little employment of 
quantitative techniques.19 Atherosclerotic plaque imaging and cerebral 
venous thrombosis are other areas where knowledge of associated thrombus 
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Appendix A.5: Reprint permission- Chapter 2 
Simultaneous R2* and quantitative susceptibility mapping measurement 
enables differentiation of thrombus hematocrit and age: an in vitro study at 3 
T. 
This article has been accepted for publication in Journal of 
Neurointerventional Surgery (2019) following peer review, and the Version of 
Record can be accessed online at http://dx.doi.org/10.1136/neurintsurg-2019-
014802  
© BMJ Publishing Group Ltd 2019: Reuse of this manuscript version 
(excluding any databases, tables, diagrams, photographs and other images or 
illustrative material included where a another copyright owner is identified) 
is permitted strictly pursuant to the terms of the Creative Commons 


















































Spencer D. Christiansen 
 
Education: 
University of Western Ontario, London, Ontario, Canada 
CAMPEP combined Ph.D./M.Sc., Medical Biophysics, April 2021 
• Research Focus: Quantitative multiparametric MR-based thrombus 
characterization 
• Supervisor: Dr. Maria Drangova 
 
University of Guelph, Guelph, Ontario, Canada 
B.Sc., Biophysics, Honours, Co-op, April 2015 
 
Honours and awards: 
2019 -2020 Ontario Graduate Scholarship ($15 000) 
          2019 ISMRM Educational Stipend ($720) 
          2018 Imaging Network of Ontario Oral Presentation,  
Honourable Mention ($100) 
          2018 ISMRM Educational Stipend ($720) 
          2017 Robarts Research Retreat Oral Presentation Award ($100) 
          2017 ISMRM Educational Stipend ($720) 
2016 -2017 Canadian Institutes of Health Research (CIHR)  
CGS-Masters Scholarship ($17 500) 
2015 -2020 Western Graduate Research Scholarship ($7800/y) 
2015 -2019 Schulich Graduate Scholarship ($2000/y)            
          2015  Harold E. Johns Summer Studentship in Medical  
Physics (declined) 
          2014 Outstanding poster presentation at the SickKids Summer 
Research Symposium 
          2012 NSERC Undergraduate Student Research Award ($4500) 
2010-2015 University of Guelph Dean’s Honours List 





University of Western Ontario, London, Ontario  
Graduate Student Research Assistant (Prof. Maria Drangova)                                       
May, 2015 - April, 2021 
 
The Hospital for Sick Children, Toronto, Ontario  
Research Assistant (Prof. Giles Santyr)                                                                              
May - December, 2014 
 
University of Guelph, Ridgetown Campus, Ridgetown, Ontario  
Lab Technician (Dr. Victor Limay-Rios)                                                                              
January - August, 2013 
 
Deep River Science Academy at Atomic Energy of Canada Ltd., Deep River, 
Ontario 
Research Assistant/Tutor (Dr. Jeremy Pencer)                                                                      
May - August, 2012 
 
Journal publications: 
1. Christiansen SD, Liu J, Bres Bullrich M, Sharma M, Pandey SK, 
Boulton M, Sposato LA, and M Drangova. “Ex vivo thrombus MR imaging 
features and patient clinical data enable prediction of acute ischemic stroke 
etiology.” Submitted to Stroke April 2021. 
 
2. Christiansen SD, Liu J, Bres Bullrich M, Sharma M, Pandey SK, 
Boulton M, Sposato LA, and M Drangova. “Quantitative prediction of stroke 
thrombus erythrocyte content from ex vivo multiparametric MRI using deep 
learning.” Submitted to American Journal of Neuroradiology March 2021. 
 
3. Christiansen SD, Liu J, Boffa MB, and M Drangova. “Simultaneous 
R2* and QSM measurement enables differentiation of thrombus hematocrit 
and age: an in vitro study at 3T.” Journal of NeuroInterventional Surgery, 
published online May 2019. 
 
4. Liu J, Christiansen SD, and M Drangova. “Single multi-echo GRE 
acquisition with short and long echo spacing for simultaneous quantitative 
mapping of fat fraction, B0 inhomogeneity, and susceptibility.” NeuroImage 





Refereed abstracts and proceedings: 
1. Christiansen SD, Liu J, Bres Bullrich M, Sharma M, Pandey SK, 
Boulton M, Sposato LA, and M Drangova. “Deep learning prediction of 
retrieved stroke thrombus RBC content using quantitative, multiparametric 
MRI.” International Society for Magnetic Resonance in Medicine (ISMRM) 
29th Annual Meeting, Vancouver, Canada May 2021. 
 
2. Qin E, Christiansen SD and M Drangova. “Prediction of stroke 
thrombus RBC content from multiparametric MRI using machine learning”. 
Imaging Network of Ontario 19th Annual Symposium, Toronto (remote), 
Ontario March 2021. 
 
3. Christiansen SD, Liu J, Boffa MB, Sposato LA and M Drangova. 
“Radiomics prediction of ESUS etiology based on ex vivo thrombus analysis 
using multiparametric quantitative MRI”. European Stroke Organization and 
the World Stroke Organization Conference, Vienna, Austria (remote) 
November 2020. 
 
4. Christiansen SD, Liu J, Boffa MB, Sposato LA and M Drangova. 
“Stroke thrombus RBC content and etiology prediction using R2* and 
susceptibility values ex vivo at 3T”. European Stroke Organization and the 
World Stroke Organization Conference, Vienna, Austria (remote) November 
2020. 
5. Christiansen SD, Liu J and M Drangova. “Deep learning prediction 
of stroke thrombus RBC content from multiparametric MRI ex vivo”. Robarts 
Research Retreat, London, Ontario June 2020. 
 
6. Qin E, Christiansen SD and M Drangova. “Investigating stroke 
origin from thrombus cellular composition”. Robarts Research Retreat, 
London, Ontario June 2020. 
 
7. Christiansen SD, Liu J, Boffa MB, Sposato LA and M Drangova. 
“Stroke thrombus RBC content and etiology prediction using R2* and 
susceptibility values ex vivo at 3T”. Imaging Network of Ontario 18th Annual 





8. Christiansen SD, Liu J, Boffa MB and M Drangova. “Evaluation of 
blood clot MR R2* and susceptibility preservation using oxygen-impermeable 
wrapping and cryogenic storage in vitro at 3T”. Robarts Research Retreat, 
London, Ontario June 2019. 
 
9. Christiansen SD, Liu J, Dunmore-Buyze J, Boffa MB and M 
Drangova. “Comparison of room temperature, refrigerator and cryogenic 
storage for preservation of blood clot R2* and quantitative susceptibility 
values in vitro at 3T”. International Society for Magnetic Resonance in 
Medicine (ISMRM) 27th Annual Meeting, Montreal, Canada May 2019. 
 
10. Liu J, Sposato LA, Christiansen SD and M Drangova. “Initial 
experience of imaging stroke patients with a 5-minute whole head multi-echo 
GRE acquisition”. International Society for Magnetic Resonance in Medicine 
(ISMRM) 27th Annual Meeting, Montreal, Canada May 2019. 
 
11. Christiansen SD, Liu J, Boffa MB and M Drangova. “Evaluation of 
blood clot MR relaxivity and susceptibility preservation using room 
temperature, refrigerator and cryogenic storage in vitro at 3T”. Imaging 
Network of Ontario 17th Annual Symposium, London, Ontario March 2019. 
 
12. Liu J, Christiansen SD and M Drangova. “A study of flip-angle 
effects in simultaneous quantification of fat fraction, susceptibility and R2*”. 
Imaging Network of Ontario 17th Annual Symposium, London, Ontario March 
2019. 
 
13. Christiansen SD, Liu J, Boffa MB and M Drangova. “Blood clot 
hematocrit and age differentiation in vitro using R2* and quantitative 
susceptibility mapping”. Robarts Research Retreat, London, Ontario June 
2018. 
 
14. Christiansen SD, Liu J, Dunmore-Buyze J, Boffa MB and M 
Drangova. “Differentiation of blood clot hematocrit and age in vitro using R2* 
and quantitative susceptibility mapping at 3T ”. International Society for 
Magnetic Resonance in Medicine (ISMRM) 26th Annual Meeting, Paris, 
France June 2018. 
 
15. Liu J, Christiansen SD and M Drangova. “Simultaneous 




acquisition: flip-angle effects”. International Society for Magnetic Resonance 
in Medicine (ISMRM) 26th Annual Meeting, Paris, France June 2018. 
 
16. Christiansen SD, Liu J, Boffa MB and M Drangova. “Blood clot 
hematocrit and age differentiation in vitro using R2* and quantitative 
susceptibility mapping”. London Health Research Day, London, Ontario May 
2018. 
 
17. Christiansen SD, Liu J, Boffa MB and M Drangova. “Blood clot 
hematocrit and age differentiation in vitro using R2* and quantitative 
susceptibility mapping”. Imaging Network of Ontario 16th Annual 
Symposium, Toronto, Ontario March 2018. 
 
18. Christiansen SD, Liu J, Boffa MB, Sposato LA and M Drangova. 
“In vitro blood clot composition characterization by quantitative MRI”. 12th 
Annual London Imaging Discovery Day, London, Ontario June 2017. 
 
19. Christiansen SD, Liu J, Boffa MB, Sposato LA and M Drangova. 
“In vitro blood clot composition characterization by quantitative MRI”. 
Robarts Research Retreat, London, Ontario June 2017. 
 
20. Liu J, Sposato LA, Whelan T, Christiansen SD and M Drangova. “A 
5-minute multi-echo GRE acquisition for multi-parametric imaging”. 12th 
Annual London Imaging Discovery Day, London, Ontario June 2017. 
 
21. Christiansen SD Liu J, Wade T, Dunmore-Buyze J, Boffa MB, 
Sposato LA and M Drangova. “Quantitative characterization of calcified and 
lipid-laden blood clot in vitro at 3T”. International Society for Magnetic 
Resonance in Medicine (ISMRM) 25th Annual Meeting, Honolulu, United 
States April 2017. 
 
22. Christiansen SD, Liu J, Boffa MB, Sposato LA and M Drangova. 
“Quantitative MR characterization of calcified and lipid-laden blood clot in 
vitro at 3T”. Imaging Network of Ontario 15th Annual Symposium, London, 
Ontario March 2017. 
 
23. Christiansen SD, Liu J, Boffa MB, Sposato LA and M Drangova. 




laden blood clot in vitro at 3T”. London Health Research Day, London, 
Ontario March 2017. 
 
24. Christiansen SD, Liu J and M Drangova. “Effect of in vitro blood 
clot hematocrit and age in quantitative R2* MRI mapping”. Robarts Research 
Retreat, London, Ontario June 2016.  
 
25. Christiansen SD, Liu J and M Drangova. “Effect of in vitro blood 
clot hematocrit and age in quantitative R2* MRI mapping”. London Health 
Research Day, London, Ontario March 2016.  
 
26. Christiansen SD, Kanhere N, Lindenmaier A, Zanette B and G 
Santyr. “Mapping hyperpolarized 129Xe polarization losses in the magnetic 
field of a 1.5T MRI system”. The SickKids Summer Research Program 
Symposium, Toronto, Ontario August 2014. 
 
Supervisory and volunteer experience: 
Undergraduate 3rd and 4th year research project mentor 
Supervised a Western medical biophysics undergraduate student for their 3rd 
year, summer and 4th research projects                                                                                                                
January 2020 - April 2021 
 
Western National Scholarship application ranking volunteer 
Read essays and ranked high school student applications for prestigious 
Western entrance scholarships                                                                                        
February, 2020 
 
M. M. Robinson High School, Burlington, Ontario 
Guest lecture (Grade 10 Science Academic)                                                                                            
May, 2018 
 
